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A. INTRODUCTION 
A. 1 Septic shock in man 
Septic shock in man often presents a dramatic clinical picture. 
The cause and mechanisms of this type of shock are still not fully 
clarified. 
The circulatory failure in patients with septic shock can have 
two different patterns: 
In one form, the circulation is hyperdynamic with an increased 
cardiac output. The patient is alert though often restless and 
has a warm, flushed skin. The pulse is full, urinary output is 
maintained, but the blood pressure is low. 
In the other form of septic shock, the circulation is hypodynamic, 
with a reduced cardiac output. The patient is pale and has cold 
extremities. A feeble pulse,severe hypotension and oliguria are 
characteristics of this hypodynamic state of shock (39,40,70,97, 
109,110,113). 
These two forms of septic shock can and often do occur subse-
quently in the same patient. 
Peripheral resistances can be found high in the hypodynamic 
state and low in the hyperdynamic state, but most authors agree 
that the peripheral resistance is mostly low in human septic shock 
(25,41 ,70,99). 
The combination of a hyperdynamic circulatory state, a decreased 
peripheral resistance and a narrowed arteriovenous oxygen dif-
ference, as is often found in human septic shock, suggests the 
opening of arteriovenous shunts (12,23,27). 
Arteriovenous shunting and vasoconstriction may be operational at 
the same time, leading to a redistribution of the circulating 
volume, in such a way that some areas have an increased blood flow 
while other areas have a reduced flow. 
The causative bacteria in septic shock are practically always 
gram-negative: Escherichia Coli in about 50% of cases, Klebsiella 
in 22-25% and Proteus in 15-20% (8,95,109). 
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Literature data indicate that it are not the intact bacteria, but 
the endotoxins from their cell walls which provoke the circulato-
ry derangement of gram-negative bacterial shock (8,49,76). 
For this reason the descriptive terms septic shock, gram-negative 
bacterial shock and endotoxin shock can be considered synonyms. 
The mortality rate of conventionally treated gram-negative shock 
in man remains high at 50% or more, according to several authors 
(22,60,78,98). 
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A. 2 Why adrenergic blockade in experimental endotoxin shock? 
Impressed by the high mortality rate of septic shock in man and 
the complexity of the syndrome, a literature survey on cause and 
mechanisms of this type of shock was made. 
The numerous publications often prove confusing and contradictory. 
Hypotension and hypoperfusion characterize shock of any aetiology, 
but in septic shock no blood disappears from the vascular compart-
ment as in haemorrhagic shock and the heart is initially not im-
paired as in cardiogenic shock (33,42). 
The main question to be answered is therefore: Where is the blood 
that is not effectively circulating? 
Apart from arteriovenous shunting, the redistribution of blood in 
the vascular bed could be explained by vasodilatation and/or 
pooling in some areas at the expense of other areas, where vaso-
constriction predominates (8). 
In septic shock endotoxins lead to the circulatory disturbances 
via release of vasoactive intermediaries (8,54). 
The question which of the possible vasoactive intermediari-es may 
cause shock in gram-negative sepsis, was studied with the help of re-
ports on basic research in this field, done by Lillehei (68,69) 
Fine (28,29,30,49) and others (11,51,57). 
Although the evidence on the subject is confusing, it appeared 
likely nevertheless, that catecholamines play an important, maybe 
even the primary role as vasoactive intermediary in endotoxin 
shock: The catecholamine hypothesis. 
It may seem paradoxical that compounds hitherto considered to be 
mainly vasoconstrictive, could be instrumental in provoking a 
state of shock that is usually thought of as being a vasodilatory 
phenomenon. 
In view of Ahlquist's concept (2) however, it might be advocated 
that this is less contradictory than originally thought, because 
in this concept adrenergic effects are distinguished in alpha-
receptor functions which are vasoconstrictive and beta-receptor 
functions which are vasodilatory. 
As vasodilatation as well as vasoconstriction probably occur in 
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septic shock, both phenomena can be explained as catecholamine 
induced. 
At this point in the literature survey it seemed that thecate-
cholamine hypothesis, Ahlquist's concept and the probability of 
vasodilatory as well as vasoconstrictive phenomena in human sep-
tic shock, should lead to a treatment in which not only one but 
both adrenergic effects would be blocked (7). 
Such a treatment should first be investigated in the animal ex-
periment. 
Separate adrenergic receptor blockades in the canine endotoxin 
shock model are documented in literature: 
alpha-blockade by Lillehei (68,69), Morris (77), Abrams (1) and 
others; beta-blockade by Berk (9,10). 
Combined adrenergic blockade in haemorrhagic shock is described 
by Halmahagyi (38). 
Documentation of such a combined adrenergic receptor blockade in 
experimental endotoxin shock could not be found in literature. 
Therefore the study of combined adrenergic receptor blockade in 
an experimental endotoxin shock model seemed justified. 
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A. 3 Choice of the experimental animal 
Though the best model for the study of a clinical condition is 
man, debatable forms of therapy should obviously first be tried 
out in the animal model. 
Subhuman primates probably resemble man most with regard to circu-
lation physiology. The "next best" experimental animal is the dog, 
big enough to get reliable shock parameters and relatively easy 
to breed and handle. 
When for practical reasons the dog was chosen as experimental ani-
mal, it was realized that there are differences in haemodynamics 
with the subhuman primate and therefore most likely also with man, 
that should be reckoned with (27). 
Pooling of blood in endotoxin shock occurs in dogs as well as in 
subhuman primates and therefore probably also in man (19,20,89). 
The areas of pooling howeve~ are different. 
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A. 4 Comparison between endotoxin- and viable bacteria shock 
Endotoxin is a lipopolysaccharide from the gram-negative bacterial 
cell wall and has since long been considered the agent responsi-
ble for producing the shock associated with gram-negative bac-
teraemia (8,60,76). 
Borden (17) first suggested that endotoxin was the shock inducing 
part of the bacteria, by producing hypotension in the experimen-
tal animal with injection of this endotoxin. Hinshaw (45) found 
no difference in a canine forelimb preparation in septic shock, 
whether produced by i.v. endotoxin or live bacteria and states 
that endotoxin is the active component following injection of 
live Escherichia Coli organisms. 
Hinshaw (47) compared the endotoxin shock model with the viable 
bacteria model in dogs, using an E. Coli strain and endotoxins 
derived from E. Coli, both in a 95% lethal dose (L.D. 95%). 
After injection of live bacteria, the fall in arterial blood pres-
sure was more gradual, but of the same magnitude as the hypoten-
sion after the injection of endotoxin. 
Motsay (79) and Wright (112) confirm the similarity between the 
viable bacteria- a-rrd endotoxin shock model, also pointing out that 
the bacteria model has a more gradual shock pattern than the endo-
toxin model. 
In the viable bacteria model, the circulatory responses are rela-
ted to the concentration of bacteria injected, necessitating exact 
counting of the amounts of culturable units of E. Coli to be in-
jected (107). 
Also the supernatant of the bacterial suspension has to be tested 
on free endotoxins. 
In the endotoxin shock model a purified, dried endotoxin prepara-
tion derived from bacterial cultures is used. 
The preparation is provided by Standardized Industrial Methods, 
using the trichloric acid extraction method,as described by 
Boivin (15,16). 
The lethality of the endotoxin preparation is verified in mice. 
Quantification of the purified and standardized endotoxin pre-
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paration seems more reliable than assessing the lethality of bac-
terial cultures. 
Even when constantly the same number of culturable units of bac-
teria are injected, the viability of the bacteria is difficult to 
assess, and the bacterial supernatant may still contain endotoxins. 
For these reasons the endotoxin shock model was preferred. 
The strongest argument in favour of the endotoxin shock model 
rather than the live bacteria model is however the fact that in 
man also,not the intact bacteria but the endotoxins from their 
cell walls are considered the agents responsible for producing 
the shock associated with gram-negative bacteraemia (17). 
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A. 5 Content of the investigation 
After a further literature survey on endotoxin shock, experiments 
were carried out in a canine endotoxin shock model, first in a 
pilot study and subsequently in the form of a main study. 
In the pilot study, the effects of several dosages of dibenzy-
line (phenoxybenzamine) as alpha-blockade and inderal (proprano-
lol) and trasicor (oxprenolol·) as beta-blockade on experimental 
endotoxin shock were analyzed. 
Some estimations of circulating endotoxin and plasma catecholami-
ne levels were performed. 
In the main study, 11 biphasiC 11 adrenergic blockade was the most im-
portant topic of interest, applying dibenzyline as premedicative 
alpha-blockade before inducing endotoxin shock and trasicor as 
medicative beta-blockade after endotoxin injection. 
Alternative forms of adrenergic blockade were also investigated. 
Results have been statistically analyzed. 
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B. 1 
B. 1-1 
B. 1-1-1 
B. LITERATURE SURVEY 
Canine endotoxin shock 
Materials and methods: 
Endotoxin 
Endotoxin from Difco Laboratories Detroit, is used by most inves-
tigators in the endotoxin shock model. Several dosages and several 
strains of endotoxin are mentioned. Mostly, 5 mgr/kg is consider-
ed a L.D. 95%, although different batches of endotoxin are used, 
as demonstrated by the following codenumbers: 
055:B4 Blattberg (13); 055:B5 : Park (82) and Guntheroth (36); 
011:84 : Rety (92) and 0127:88 : Brockman (18) and Thomas (106). 
B. 1-1-2 Influence of route of endotoxin administration 
Jacobson (52) found only small quantitative differences in the 
early haemodynamic pattern of experimental endotoxin shock after 
administration of endotoxin along different routes. 
The overall effects on portal venous hypertension, systemic ar-
terial hypotension and the increase in small intestinal vascular 
resistance were the same, whether the injection of endotoxin was 
either in the portal circulation, in a femoral vein or in the me-
senteric artery. 
The femoral vein is thus usually chosen as route of endotoxin ad-
ministration. 
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B. 1-1-3 Influence of injection time 
In the patient, endotoxaemia develops gradually, probably over 
several hours. For this reason the common method of producing ex-
perimental endotoxaemia in the dog by rapid injection of a lethal 
dose may not represent accurately the clinical situation in man. 
Rety (92) therefore studied the effects of slow infusion of a 
lethal dose of endotoxin in the dog and compared these with the 
effects after rapid injection. 
Haemodynamics deteriorated progressively and in the same 
magnitude, but more gradually than after rapid injection. The 
pattern of shock at the end of two hours was identical with that 
produced by rapid injection. The conclusion is that the rapid in-
jection technique seems to be as good as the slow infusion tech-
nique and gives better opportunity to compare haemodynamic data. 
B. 1-1-4 Endotoxin detection 
Since not the intact bacteria, but the endotoxins of their cell 
walls cause shock, a reliable test that quantifies the endotoxins 
rather than the bacteria itself, would be an improvement in deal-
ing with this type of shock in clinical as well as in experimen-
tal situations. 
Levin (61,62) and Reinhold (91) proposed the use of such a test in 
vitro: the Limulus lysate assay for circulating endotoxins in gram-
negative sepsis. 
The assay depends on the gelation by endotoxin of an amoebocytes 
lysate ,derived from the blood of l imul us polyphemus, the horseshoe 
crab (62,91). 
The Limulus lysate is incubated in pyrogen-free glassware with the 
plasma to be tested on endotoxin content. 
To avoid possible protein interference with the gelation process, 
the samples can either be diluted or deproteinized by chloroform 
extraction (26,61,62,91). 
Levin (62) and Reinhold (91) claim a good correlation between po-
sitive tests and proven bacteraemia. 
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Others report more false positive and false ·negative results with 
the test (26). 
Another test is based on a sharp increase of sensitivity to endo-
toxins in mice after pretreatment with actinomycin 0 (87): 
the Actinomycin 0-test for endotoxins. This test is more time 
consuming than the Limulus lysate test. 
The test is performed by mixing a constant dose of actinomycin 0 
with dilutions of the endotoxin containing preparation, and injec-
ting the mixtures into the peritoneal cavities of groups of mice. 
In 48 hrs., the number of deaths in each group of mice is tabula-
ted and the L.O. 50% is calculated. This L.o·.so% value reflects the 
endotoxin content of the preparation to be tested (87). 
11 
B. 1-2 Symptomatology of canine endotoxin shock 
Haemodynamics: 
Brockman (18) and Thomas (106) injected 5 mgr/kg bodyweight 
Escherichia Coli endotoxin i,v. in dogs (127:B8 Difco Laboratries, 
Detroit, Boivin extraction method) and registrated the following 
haemodynamic changes: immediately after injection, arterial pres-
sure and cardiac output fell abruptly to levels averaging 29 and 
17% of the control values respectively (the first phase of shoe~. 
In all experiments, within 10 min. there followed a rise in blood 
pressure and cardiac output to a mean value o~~2 and 50% of con-
trols. Thereafter, blood pressure and cardiac output declined a-
gain, taking a final downward course (the second phase of shock), re-
sulting in death of the experimental animal. 
Portal vein pressure rose initially with an average of 28% of control. 
This elevation continued approximately for 15 min. before retur-
ning to control values. 
Lillehei also describes this biphasic pattern of endotoxin shock 
in dogs, using an average of 7,5 mgr/kg of a crude endotoxin prepara-
tion (68,69). 
In these experiments the mean blood pressure fell also precipi-
tously to shock levels after endotoxin administration and retur-
ned to normal within 5 min. 
Sixty to 90 min. later, a second, more gradual fall in blood pres-
sure began and continued unti 1 death, in most cases within 12 hrs. 
Others confirm this biphasic shock pattern in canine endotoxin 
shock (13,71,77). 
Brockman (18) showed that when the liver was bypassed with a por-
tocaval shunt, a more gradual fall in systemic arterial blood 
pressure after endotoxin was noted. 
The rise of portalvenous pressure, and the prevention of severe 
shock after bypassing the liver suggests hepatosplanchnic pool-
ing of blood in the first phase of endotoxin shock in dogs. 
McLean (71) performed experiments, designed to determine the 
relative importance of the liver and intestine in producing the 
immediate hypotension, observed following endotoxin injection 
in dogs. 
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In experiments after evisceration and hepatectomy, injection of 
endotoxin did not result in the immediate and precipitous blood 
pressure drop, as seen in controls after endotoxin injection. 
Only in the second phase, after about 20 min., a slow progressive 
decline in blood pressure occurred. 
When the animals were eviscerated, but the liver and its blood-
supply from the hepatic artery were preserved, the response to 
endotoxin was indistinguishable from controls, with an immediate 
blood pressure drop after endotoxin injection. 
These results suggest that the hepatosplanchnic pooling of blood 
in the first phase of endotoxin shock in dogs occurs mainly in 
the 1 iver. 
Froneck (32) demonstrated a hepatic outflow block in dogs, sub-
jected to endotoxin shock. 
Contraction of the muscular sphincters in the hepatic outflow 
tract could lead to the trapping or pooling of blood in the liver 
of dogs in early endotoxin shock. 
Blattberg (13,14) found indications that early pooling in respon-
se to endotoxin might also occur outside the hepatosplanchnic 
area: when portalvenous pressure in canine endotoxin shock was 
kept constant by means of a rollerpump connected to the jugular 
vein, the arterial pressure decreased nevertheless in the first 
phase of shock. 
Occlusion in the arterial inflow in the splanchnic area did not 
prevent an early blood pressure drop either in Blattberg's 
experiments (13,14). 
Some of the evidence of early hepatic and probably also extra-he-
patic pooling has thus been presented and gives most likely an 
adequate explanation for the first phase of endotoxin shock in 
the dog. The variability and the differences in set up of the ex-
periments described, make it however difficult to draw firm con-
clusions. To understand the cause of the second progressive phase 
of endotoxin shock is still more difficult. 
Venous pooling in the lungs, the intestinal venous system and 
other systemic veins is thought to occur in later phases of endo-
toxin shock (13). The increase in venous capacity is supposedly 
so much diffuse, that it might not be accurately observed in a 
given vascular system (18). 
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Arteriovenous shunting may occur in the splanchnic and renal cir-
culation, and possibly also in other areas. (5,6,24). 
Hinshaw (44) claims to have demonstrated that pooling in the 
splanchnic area may not only be operative in the first phase, but 
also in the second phase of endotoxin shock. 
In another study, Hinshaw (45) found no weight increase in canine 
forelimb preparations after endotoxin and thus no signs of tissue 
oedema or loss of blood in the leg, muscles or skin. 
This seems to exclude these areas as possible sites of pooling 
Hermreck (41), Isakson (50) and Passmore (84) measured increased 
renal inflow in late sepsis attributed to vasodilatory substances 
from the septic areas, indicating the kidneys as potential pool-
ing sites. 
Findings by Hinshaw (45) suggest the absence of a direct toxic 
action of endotoxin on the myocard in dogs. 
Kondo (58) found in a transplantation model no myocardial depres-
sion by endotoxin either. 
More recent work by Hinshaw and co-workers however, emphasizes 
that in later stages of canine endotoxin shock, catecholamine-
induced myocardial dysfunction might occur (4, 43, 74, 85). 
Haemodynamics in the second progressive phase of endotoxin shock 
are furthermore probably influenced by the profound hypoglycaemia 
that characterizes this terminal stage (46,72,86). 
It can be concluded that the problem of vasodilatation or vaso-
constriction in late pooling and the question of pooling sites in 
the second shock phase seems not yet clearly solved. 
Intestinal manifestations: 
Lillehei (66,68) describes severe changes in the microcirculation 
of the mesentery in canine endotoxin shock. 
Shortly after endotoxin administration there is a 11 Wave of vaso-
constriction" in the small vessels of the mesentery. 
This is followed by a progressive dilatation of the arteriolae 
and venulae and 
In 4 + 5 h rs. , 
stagnant anoxia, 
congestion in the capillary bed. 
mucosal congestion and eventual necrosis,due to 
follows. Prior to death, a watery diarrhea 
changing to haemorrhagic diarrhea is a common occurrence. 
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At autopsy, extensive haemorrhagic necrosis of the mucosa is seen, 
most severely in the small intestine. This bowel necrosis must 
result from critical ischaemia due to vasoconstriction and oli-
gaemia, because it could be prevented by adequate perfusion of 
the superior mesenteric artery. 
Others also described vasoconstriction in the microcirculation of 
the mesentery in canine endotoxin shock (88,93). 
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B. 2 Vasoconstriction in the hepatosplanchnic area 
B. 2-1 Final common pathway theory 
When an experimental animal is bled into a reservoir,the ensuing 
hypotension is reversible and can be corrected by re-infusing the 
blood from the reservoir back into the animal as long as a certain 
amount of exsanguination is not exceeded. 
A point of irreversibility can be reached after which re-infusion 
does not restore the animal from its shock. 
Lillehei (65,67) demonstrated that the severe bowel necrosis charac-
teristic for endotoxin shock also occurs in the late phase of 
haemorrhagic shock. 
The explanation would be that the intestinal wall after prolonged 
ischaemia and anoxia loses its barrier function against the pas-
sage of the intestinal bacteria into the bloodstream. 
The result is tha·t the "shocked" gut leaks bacteria and therefore 
endotoxins into the circulation and the hitherto haemorrhagic 
shock becomes endotoxic in nature. 
Fine (49) endorses this theory by measuring elevated levels of 
endotoxins in late haemorrhagic shock, applying the Limulus ly-
sate test, but Mee (73) could not duplicate this finding. 
Mesenteric vasoconstriction resulting in critical ischaemia of the 
bowel and leakage of endotoxin would therefore be the common do-
minator in the endphase of both haemorrhagic and endotoxin shock 
in dogs: the intestine as final common pathway. 
Fine (28,29) and Palmerio (81) thus believe that the state of irre-
versible shock in exsanguination is due to endotoxaemia. 
Additional evidence for the final common pathway theory is found 
in the fact that after ligature.occlusion of the superior mesen-
teric artery in dogs on release of the ligature, a full blown 
syndrome of shock develops, indistinguishable from endotoxin 
shock (28,81). 
Furthermore,other studies showed that oral administration of mas-
sive amounts of antibiotics and cross perfusion with fresh blood 
could prevent lethal irreversibility in experimental haemorrhagic 
shock (29,81). 
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Finally, Fine demonstrated that animals made resistant to endo-
toxin by injection of increasing amounts of endotoxin were also 
resistant to otherwise lethal degrees of haemorrhagic shock (28, 
29,81). 
Endotoxin shock is thus seen as a self perpetuating condition, in 
which the basic haemodynamic mechanism is vasoconstriction. 
Swan (102) however, challenges the final common pathway theory 
pointing out that in dogs the mesenteric vasoconstriction after 
injection of endogenous catecholamines is followed by a secondary 
vasodilatation. 
Others state that endotoxin is a vasodilator or initiates release 
of vasodilating substances, and that vasoconstriction is a compen-
satory mechanism, impairing the circulation in a later phase by 
an overresponse (94) .In summary however,one can presume in view of 
the above mentioned studies, contradictory as they may be, that 
in any case vasoactive intermediaries can be postulated to play 
an important role in endotoxin shock. 
B. 2-2 R.E.S. and detoxification 
Normal spleen and liver, which together contain the major part of 
the R.E.S. (reticulo-endothelial system), extract and detoxify 
circulating endotoxins (29). 
In the laboratory, an enzyme preparation from a normal spleen de-
toxifies 50 times its own weight of endotoxin. 
The same preparation from the spleen of an animal in shock is in-
active, whereas that from an animal with completely denervated 
spleen in shock remains as active as the preparation from normal 
spleen (30). 
Fine (30) found such a detoxifying function in the liver as well. 
Other evidence of endotoxin detoxification in the 1 iver and spleen 
of dogs in endotoxin shock is described by Fine (29,30): implan-
ting a donor liver or spleen in the animal in endotoxin shock im-
proved haemodynamics. 
Cross circulation through a freshly excised homologous liver gave 
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comparable results. Splenectomy prior to the shock procedure 
resulted in death within a few hours. 
Treatment of the shocked dog with fresh splenic extract intrave-
nously improved survival. Liver and spleen therefore seem to have 
the same endotoxin detoxifying potential. 
Since the only function shared by the spleen and the liver is the 
reticulo-endothelial function, surviving seems to be dependent on 
the integrity of the R.E.S. in the liver and spleen and more es-
pecially on the accessability of this system to the circulation 
for clearance of endotoxin. 
Impaired flow through liver and spleen,caused by vasoconstriction 
in the hepatosplanchnic area, as might occur in endotoxin shock, 
thus could prevent endotoxin detoxification. 
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B. 3 Possible vasoactive mediators in endotoxin shock 
Introduction 
All sorts of compounds have been implicated as vasoactive inter-
mediaries in gram-negative shock: the catecholamines, histamine, 
serotonine and kinins (49). 
If a vasoactive substance would be responsible for shock in gram-
negative sepsis, it should fulfill the following conditions: 
1. Infusion of the compound in the experimental animal should 
lead to a circulation pattern comparable to septic shock. 
2. The level of the compound should be elevated in endotoxin 
shock (51,53,54,57). 
While reports on the subject in literature are conflicting, some 
of the data on possible vasoactive intermediaries are given here, 
taking into acount the above mentioned criteria. 
B. 3-1 Catecholamines 
Lillehei (67) produced a lethal form of shock in the dog by the 
intravenous administration of 17 "g/kg/min. of epinephrine for 90 
minutes. This produced initially an intense ischaemic anoxia with-
in the visceral organs, followed by congestion and stagnation of 
blood. 
The effect on blood flow and vascular resistance in visceral or-
gans was similar to that found in endotoxin shock. The animals all 
died (average survival time: 20 hrs. ) and autopsy findings also 
were similar to that described for endotoxin shock. 
As early as 1940, Freeman already produced shock in dogs by infu-
sion of epinephrine (31). 
Yard (114) described shock in dogs produced by norepinephrine in-
fusion. 
Berk (9) found a decrease in blood flow and blood pressure during 
epinephrine infusion in dogs with an increased portal flow and 
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pooling in the liver. 
When the infusion was discontinued,the animals gradually relap-
sed into a state of irreversible hypotension. 
Jacobsen (54) found only a late fall of blood pressure after ca-
techolamine infusion in dogs. 
Measurements of catecholamines during endotoxin shock were done 
by Lillehei, who measured a 10+30 fold rise in the plasma ca-
techolamines, immediately after the injection of endotoxin in 
dogs (66). This was followed by a return to less abnormal, but 
still elevated levels. Near the time of death of the experimental 
animals,the catecholamines rose again to high levels. 
Jacobsen (54) also found increases of plasma epinephrine levels 
after endotoxin injection in dogs.Griffiths finally, found in-
creased epinephrine- and norepinephrine levels in canine gram-
negative bacteraemia (35). 
B. 3-2 Histamine and serotonine 
Weil (111) found a sharp rise of blood histamine immediately after 
endotoxin injection in dogs. 
Vick (108) also measured elevated plasma histamine levels both in 
early and late endotoxin shock in dogs. 
Jacobsen (53,54~ however,found no significant increases of hista-
mine levels in canine endotoxin shock. Serotonine concentrations 
were even decreased after endotoxin. 
Histamine and serotonine infusions did not lead to the major 
early vascular responses as seen after endotoxin injection. 
Prior treatment of dogs with chemicals that reduce tissue stores 
of vasoactive substances (i.a. cortison• acetate and reserpine) 
failed to prevent the typical haemodynamic events of endotoxaemia. 
Miller (75) also states that although histamine, serotonine (or 
bradykinin) may mimic the vascular respo~se of the early phase 
of endotoxin shock, the rise in plasma concentrations of these 
three compounds during endotoxin shock is transient and counter-
acting drugs (i.a. phenothiazines, methysergide and salicylates) 
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do not alter the development or course of the vascular reactions 
to endotoxin. 
Lichtenstein (64) indicates that catecholamines,but also some en-
dotoxins could in fact inhibit histamine release. 
B. 3-3 Kinin and bradykinin 
Shah (96) could not duplicate in dogs findings of authors who 
measured significantly elevated kinin levels in the first phase 
of endotoxin shock in monkeys. 
Although in dogs after endotoxin the level of bradykinin in the 
portal blood rose slightly above that in the hepatic vein and fe-
moral artery, bradykinin levels were not statistically different 
from pre-injection values or from each other. 
Carretero (21) found no detectable amounts of kinin after endo-
toxin. 
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B. 4 The catecholamine hypothesis 
B. 4-1 Alpha- and beta receptors 
Ahlquist (2) postulated that there are two different types of re-
ceptor sites with which a sympathicomimetic agent can react to 
elicit a response. 
These receptor sites, which he termed 1'alpha''and'1 beta'',were classi-
fied on the basis of their responses to a variety of sympathico-
mimetic amines. 
The hypothesis gained support from the development of specific 
blocking agents for each receptor type. 
The alpha-adrenotropic receptor is associated with most of the 
excitatory functions (vasoconstriction) and one important inhibi-
tory function (intestinal relaxation). 
The beta-adrenergic receptor is associated with most of the in-
hibitory functions (vasodilatation and inhibition of bronchial 
musculature) and one important excitatory function (myocardial 
stimulation). 
In the original concept a differentiation was made between the so 
called ''pure adrenergic amines'', phenylephrine and isoproterenol, 
and the ''mixed amines'', epinephrine and norepinephrine (104). 
The pure amines would react with only one type of receptor, 
giving therefore a receptor specific effect: phenylephrine vaso-
constrictive and isoproterenol vasodilatory. The mixed amines 
would possess the potential for combined receptor stimulation, with 
a relative specificity for one of the two. 
Thus, in the classical view, norepinephrine is considered predo-
minantly an alpha- and epinephrine a beta stimulant. 
Swan (104,105) showed in two critical studies with catecholamine 
infusion experiments in dogs after alpha- and/or beta-blockade, 
that the so called ''pure 1' amines phenylepinephrine and isoprote-
renol also reacted with the alternative receptor. 
Thus, they cause a combined receptor stimulation as well, like the 
naturally occurring mixed amines epinephrine and norepinephrine. 
In Swan 1 S studies it was confirmed that norepinephrine had alpha-
and beta effects with a slight preponderance of the alpha function. 
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Epinephrine also displayed both properties, but had a more sig-
nificant beta effect. The double properties were sequential: 
norepinephrine and epinephrine had both an initial vasoconstric-
tive and a secondary vasodilatory effect. 
B. 4-2 Circulating or locally released catecholamines? 
Palmerio (81) and Fine (29) subjected dogs to haemorrhagic or en-
dotoxin shock after coeliac blockade. 
After denervation of the splanchnic area by coeliac blockade, a 
significant decrease in mortality rate was found. Moreover, are-
markable improvement in systemic haemodynamics and preservation 
of the functional and structural integrity of the tissues in the 
denervated area was seen. Specifically, in dogs with all of the 
intestine except the distal half of the colon denervated, the 
only part which showed haemorrhagic necrosis was the non-denerva-
ted portion. 
This is considered as proof that norepinephrines released in the 
tissues and not the circulating catecholamines are responsible 
for the tissue injury and the eventual vascular collapse. 
As for the reliability of the blockade, authors state that they 
got complete and sustained blockade by ganglionectomy or with nu-
percaine hydrochloride in oil, injected under direct vision into 
the coeliac ganglia (29,81). 
The blockade is not secured by readily absorbed local anaesthe-
tics. Proof of effective blockade was obtained by assaying the 
norepinephrine content of the tissues. 
Apart from shock experiments with denervation of the splanchnic 
area, Fine worked with denervated and half denervated spleen pre-
parations (28,29,30). When half of the exteriorized spleen is de-
nervated and the other half not, the response of the denervated half to 
haemorrhage is remarkablydifferentfrom that of the other half. 
The non-denervated half contracts immediately to about one third 
of its normal size and remains shrunken. 
The denervated half of the spleen on the other hand, does not 
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change in size or appearance throughout the period of shock. 
If one injects 100 .~gr. norepinephrine i .v. early in the course 
of the experiment, that is before haemorrhage, both halves of the 
spleen contract vigorously. 
Fine concludes from both observations, that since the sensibility 
of the denervated half to circulating catecholamines is at least 
as much as that of the non-denervated half, it follows that the 
contraction of the latter in response to haemorrhage is not caused 
by circulating catecholamines, but by norepinephrine released 
from its store in that half of the spleen. 
These effects of denervation also apply to shock,produced by a 
lethal dose of endotoxin, given intravenously. 
The conclusion is therefore that in endotoxin shock also,locally 
released catecholamines are responsible for the functional and 
structural damage in the splanchnic area as well as for the pro-
gressive failure of the systemic circulation. 
B. 4-3 Alpha-adrenergic blockade 
Lillehei (66,68,69) investigated the effect of pretreatment with 
0,5->2,5 mgr/kg dibenzyline (phenoxybenzamine) in endotoxin shock 
in dogs. The dose of endotoxin used in these experiments was 
7,5 mgr/kg bodyweight of a crude endotoxin preparation. 
Dogs given dibenzyline did have the characteristic primary drop 
in blood pressure, but the secondary fall in 60-> 90 minutes rare-
ly went below 80 mm Hg. 
By 4 hrs. following endotoxin, the blood pressure had returned 
to pre-injection levels. These dogs did not get diarrhea and at 
sacrifice the bowel was normal. 
Nine out of 10 dogs survived permanently, whereas in the control-
group the endotoxin proved fatal for 90% of dogs. Other authors 
could not duplicate Lillehei's findings however, neither as far 
as survival improvement after alpha-blockade is concerned, nor 
with regard to the blood pressure in the second shock phase. 
Morris (77) for example, injecting 2 mgr/kg endotoxin in 10 dogs 
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after pretreatment with 0,9 mgr/kg dibenzyline, saw an improve-
ment in the first phase of shock, whereas Lillehei did not. 
There was no improvement in the second phase and therefore in the 
ultimate picture of the endotoxin shock in these experiments, 
whereas Lillehei noted a clear improvement after dibenzyline pre-
treatment in this later phase. 
The dosages however,are different and this factor may have in-
fluenced the results. 
Abrams (1) states that,if dibenzyline has any effect on endotoxin 
shock in dogs, it must be related to the additional fluid supple-
tion. 
Iampietro (48) prevented with 10 mgr/kg dibenzyline at least par-
tially the precipitous drop in blood pressure immediately after 
injection of 2 mgr/kg endotoxin in dogs. Dibenzyline did not pre-
vent a gradual lowering of arterial pressure in the second phase 
(Scheme, p. 26). 
B. 4-4 Beta-adrenergic blockade 
Berk (11) investigated the effect of beta-adrenergic blockadewith 
inderal (propranolol) in canine endotoxin shock. 
A total of 90 dogs was injected with 0,5 mgr/kg Endotoxin coli 
(Difco 127:88). The dogs were divided into the following groups: 
Group 1: 36 dogs, untreated, functioning as controlgroup. 
Group 2: 32 dogs, treated with an average of 0,05 mgr/kg inderal 
after the endotoxin injection and also recei-
ving additional i.v. therapy, consisting of 
Ringer 1 S solution, sodiumbicarbonate, atropin, 
dextrose and calciumchloride and in some cases 
digitalin. This additional therapy was necessary 
to combate early bradycardia and terminal 
arythmia•s. 
Group 3: 22 dogs, receiving this additional therapy after endo-
toxin, buth without inderal. 
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The survival rate in group 1, the untreated dogs, was 19%. 
In group 2 with inderal and additional therapy, the survival 
rate was 78% and in group 3 with the same regimen, but without 
inderal ,it was 27%. 
These differences between all three groups appeared significant 
with P<O,OOL 
The dogs that were given endotoxin and then treated with inderal 
showed haemodynamic patterns that were different from those,given 
endotoxin only. These dogs did have the early hypotensive phase 
of endotoxin shock, but the second phase was less severe. 
Dibenzyline Jndera 1 
dose dose Improvement Improvement Improvement 
-- --
mgr/kg mgr/kg of first of second of 
-
Author bodywei ght bodywei ght shock ehase shock ehase survival 
---
Lillehei 
(68,69) 0,5 + 2,5 - - + + 
Morris 
(77) 0,3 - + - -
Abrams 
( 1) 1 - - - -
Jampietro 
(48) 10 - + - -
Berk 
( 11) - 0,05 - + + 
(+ additional 
therapy) 
Scheme Anti-adrenergic effects, found by various authorL 
26 
B. 5 Summary 
In the canine endotoxin shock model, 5 mgr/kg bodyweight endo-
toxin (Difco Laboratories, Detroit) i.v. would lead to shock with 
a mortality rate of 95% of the experimental animals (L.D. 95%). 
Circulating endotoxins can be detected with the Limulus lysate-
and Actinomycin 0-tests. 
Endotoxin shock in dogs has a biphasic pattern with regard to 
blood pressure and blood flow. 
In the first phase of this biphasic shock pattern, hepatosplanch-
nic pooling is the predominant feature. 
Vasoconstriction in the hepatic outflow tract could lead to this 
pooling. In the second phase of canine endotoxin shock, haemody-
namics are more difficult to understand. 
In the first phase,severe changes in the microcirculation of the 
mesentery, leading to haemorrhagic necrosis of the mucosa,is also 
a constant finding. 
The resulting ischaemia of the intestinal wall would lead to 
leakage of the intestinal bacteria into the bloodstream. 
Any type of shock leading to hypocirculation in the intestines 
thus can become endotox.ic in nature in its endphase. 
Vasoconstriction may prevent the R.E.S. in liver and spleen from 
detoxifying the endotoxins. 
Circumstantial evidence for a role of the catecholamines in canine 
endotoxin shock is found in the observation that catecholamine 
infusions lead to circulation disturbances, comparable to that in 
endotoxin shock. 
Plasma catecholamine levels are found elevated in endotoxin shock. 
Histamine, serotonine and the kinins might also have some influ-
ence on the syndrome. Catecholamine effects are not uniform: 
alpha- and beta-receptor functions are connected with vasocon-
striction and vasodilatation respectively. 
The catecholamines epinephrine and nor-epinephrine have a combined 
receptor-stimulating effect, with some preponderance for one or 
the other. These double properties are sequential. 
Shock experiments after denervation of the splanchnic area and with 
half denervated spleen preparations implicate the locally released 
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and not the circulating catecholamines as the vasoactive inter-
mediary. 
Lillehei and others (68,69) experimented with alpha-adrenergic 
blockade in canine endotoxin shock.Berk (11) did the same with 
beta-adrenergic blockade. The results are contradictory. 
Combined alpha- and beta-adrenergic blockade in canine endotoxin 
shock has not been described in literature. 
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C THE EXPERIMENTS 
C. 1 The working hypothesis 
As a result of the literature survey and the considerations des-
cribed in chapter B , the following working hypothesis was for-
mulated as the basis for the present study: 
1. In canine endotoxin shock the first shock phase is for an im-
portant part caused by alpha-adrenergic influences, and the 
second phase by beta-adrenergic influences (Fig.1). 
2. Anti-adrenergic treatment can only be effective when alpha-
blockade is directed to the first, and beta-blockade to the 
second shock phase: thus, combined biphasic-adrenergic 
blockade would be indicated in canine endotoxin shock (7). 
blood 
pressure 
0 
endotoxin 
pooling in the liver 
1 hour time 
Fig. 1. Schematization of endotoxin shock pattern and working 
hypothesis. 29 
c. 2 Pilot study 
To be able to test the working hypothesis a number of preliminary 
questions, formulated in the following objectives, had first to 
be answered in a pilot study, before starting a more extended 
study. 
C. 2-1 Objectives 
1. Analysis of influence on survival in canine endotoxin shock of 
various dosages anti-adrenergics: 
dibenzyline (phenoxybenzamine) as alpha-blockade, inderal ~ro­
pranolol) and trasicor (oxprenolol) as beta-blockade. 
These anti-adrenergics were given either before endotoxin in-
jection (premedication), after endotoxin injection (medication) 
or premedicative as well as medicative in a biphasic sequence. 
2. Analysis of vasodilatory effects of increasing dosages of di-
benzyline and additional trasicor. 
3. Estimation of circulating endotoxin in experimental canine en-
dotoxin shock. 
4. Estimation of plasma catecholamine levels in experimental 
canine endotoxin shock. 
C. 2-2 Materials and methods 
The experimental animal :the experiments were performed in mongrel 
dogs, weighing from 10 + 25 kg. 
Endotoxin: shock was induced by i.v. injection of Endotoxin coli, 
codenumber E. coli 0127:B8 (Difco Laboratories, Detroit). 
In all experiments the same dose of 5 mgr/kg bodyweight was 
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applied, supposedly a L.D. 95%, thus following the shock model of 
Brockman (18), Thomas (106) and others (71). 
The endotoxin was suspended in 25 ml Ringer's solution and injec-
ted i.v. in 1 min. via the femoral vein. 
Alpha-blockade was achieved with dibenzyline (phenoxybenzamine), 
a potent, longworking specific alpha-blockin9 agent (1,48,66). 
Beta-blockade was achieved with inderal (propranolol) or trasicor 
(oxorenolol). Inderal and trasicor have both a negative chronotropic 
effect on the heart, but trasicor has a significantly less marked de-
pressive effect on myocardial contractility (less negative inotropic 
effect) (34,63,80,83).0ibenzyl ine, inderal and trasicor were applied 
in a slow (q hr.) i .v. infusion, each chemical suspended in 500 ml 
Ringer's solution. All dogs, controls included, received the same 
amount of fluid. Premedication meant that the anti-adrenergic com-
pound was infused in 1~ hr. before endotoxin injection. Medication 
meant that the compound was infused also in 1~ hr., infusion starting 
after injection of endotoxin. 
Biphasic treatment consisted of premedicative infusion of the alpha-
blocker and medicative infusion of the beta-blocker. 
With regard to the dosages of the anti-adrenergics used, the first 
series of experiments were performed with dibenzyline doses up to 
3,5 mgr/kg bodyweight, which is about the dose considered by several 
authors to be the maximum dose (1,68,69,77). 
Only Iampitero (48) gave dibenzyline dosages up to 10 mgr/kg body-
weight (Scheme,p.26).The inderal dosage in these first experiments 
was 0,05 mgr/kg bodyweight, according to Berk (11). The dosages of 
dibenzyline and inderal were increased in later experiments. 
Dibenzyl ine was given in doses up to to 15 mgr/kg bodyweight 
and in some experiments in even a higher dose. 
Inderal was given in doses up to 0,5 mgr/kg and also in some ex-
periments in even a higher dose. 
Trasicor was primarily applied in high doses:1,5 mgr/kg bodyweight 
and once in a dose of 3 mgr/kg bodyweight. 
Experiments were performed under a 1 i ght o2 -N 20-fl uothane-anaesthes i a 
with intubation and with spontaneous respiration. 
The analysis of the vasodilatory influence of dibenzyline was perfor-
med with blood flow measurements in the femoral artery of the dog 
An electromagnetic flowprobe, Nikotron 372M, was fitted 
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around the femoral artery and the blood flow curve registrated on 
the Elema-recorder with frequent zero-adjustments, using the Ni-
kotron transducer. Endotoxin circulation was estimated in a limi-
ted number of experiments, using the Limulus lysate test or the 
Actinomycin D-test in mice. 
Plasma catecholamine determinations were performed in some ex-
periments, using the extraction procedure as described by Anton 
(3) and the fluorometric assay as described by Laverty (59). 
C. 2-3 Analysis of survival with adrenergic blockade 
Results: 
Table 1 gives the number of dogs in the various experiments, the 
dosages of anti-adrenergics applied, and in the last column the a-
verage survival times in hours with the shortest and longest survi-
vals of that group between brackets. 
Num- Endotoxin Alpha Beta- Average 
ber mgr/kg blockade blockade survival 
of bw dibenzyline 1naera1 tras1cor in Exp. Treatment dogs mgr/kg mgr/kg mgr/kg hours 
bw bw bw. 
0 Medication 4 0 15 0,5 3 >14 days 
1 died 
1 No medication 8 5 ( 2~) 6 (12) 
2 Premedication 7 5 3,5 -}- 15 0, 05->(), 5 ( 1 ) 9 @5) 
3 Medication 4 5 15 + 20 0,5+1,5 ( 1 ) 16 (43) 
4 Premedication 5 5 3,5 - ( 2~) 8~(19ili) 
5 Premedication 3 5 15 - (20) 24 (28) 
6 Biph. block. 7 5 15 1,5 (20) 37 (58) 
7 Biph. block. 1 5 30 3 14 
Table 1. Survival after various dosages anti-adrenergics. 
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Statistical analysis of survival times: 
Applying the Mann-Whitney-U-test at a significance level of alpha~,05. 
the differences in survival times between the various experiments 
were tested (1 01). 
Differences in survival times between the experiments 1,2 and 3 
were not significant. 
The differences between the experiments 1, 4, 5, and 6 were as 
follows: 
Group 1 versus 4 p- value 0,416 not significant 
Group 1 versus 5 p- va 1 ue 0,006 significant 
Group 1 versus 6 p- va 1 ue 0,001 significant 
Group 4 versus 5 p- va 1 u e 0,018 si9nificant 
Group 4 versus 6 p- value 0,002 significant 
Group 5 versus 6 p- value 0,058 not significant 
Discussion and conclusions: 
As far as the relationship between dosage and survival time is 
concerned, dibenzyline in a dose of 3,5 mgr/kg bodyweight made 
no difference with no treatment at all (group 1 versus 4), but 
dibenzyline in a dose of 15 mgr/kg bodyweight did (group 1 versus 
5). Even the difference between dibenzyline in a dose of 
3,5 mgr/kg bodyweight and 15 mgr/kg bodyweight is significant 
(group 4 versus 5). 
So is the difference between biphasic treatment and no treatment 
also in favour of the therapy (group 1 versus 6). The difference 
between dibenzyline in a dose of 15 mgr/kg bodyweight and bipha-
sic treatment with combined dibenzyline and trasicor in high doses 
(15 mgr/kg and 1,5 mgr/kg resp. ) is (just) not significant 
(group 5 versus 6). 
Therefore, alpha-blockade only, with dibenzyline in a high dose 
(15 mgr/kg bodyweigh~ as well as biphasic alpha-beta-blockade 
with dibenzyline (15 mgr/kg bodyweigh~ and trasicor ~,5 mgr/kg 
33 
bodyweight) in high doses, both improved survival significantly. 
Any combination with inderal did not improve survival. 
As a result of these preliminary experiments, the dosages chosen 
for the further studies were rather arbitrarily: 15 mgr/kg body-
weight dibenzyline and 1,5 mgr/kg bodyweight trasicor. 
C. 2-4 Analysis of vasodilatory effects of adrenergic blockade 
After release of an occlusion of an artery,the flow through that vessel 
is under normal circumstances temporarily enhanced. The empty vessel-
bed beyond the occlusion is dilated under the impact of the sud-
den thrust of blood that is liberated after release of the blood 
passage through the vessel (37). 
After some time, the blood flow normalizes again. 
This sequence is called ''reactive hyperaemia' (R.H.) and depends 
on the expansibility or compliance of the vessel. 
The peak systolic reactive hyperaemia (P.S-R-H.) is the difference 
between the peak flow in stationary state(P.F.S.) and the 
maximum peak flow in stationary state(M.P.F-S.) immediately after 
this desocclusion of the vessel (R-H-= M-P-F-S.-P.F-5-) (Fig.2,p.35). 
Occlusioo and release of the occlusion is regularly perfor-
med in flow measurements by placing a clamp proximal from the 
probe, which,together with a clamp distal from the probe,makes 
zero-adjustments possible. 
This gives the opportunity to measure the reactive hyperaemia and 
to analyze as well the vasodilatory effect of alpha-blockade with 
dibenzyline in various dosages. 
Results: 
After infusion of dibenzyline, in all experiments a decrease of 
reactive hyperaemia was seen. In one experiment (exp. 7) up till 
30 mgr/kg was infused before endotoxin (5 mgr/kg) was given. 
In this experiment also a high dose of trasicor (3 mgr/kg) was 
given. Fig. 2 demonstrates the change in reactive hyperaemia 
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Fig. 2. Reactive hyperaemia after 0 mgr, 15 mgr. and 30 mgr/kg 
dibenzyline (A,B and C resp.): 10 mm in the registration 
corresponds with a pulsatile flow of 122 ml/min. 
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during dibenzyline infusion in this experiment: 
A. is the R.H. before dibenzyline infusion, B. illustrates the 
decreased reactive hyperaemia after infusion of 15 mgr/kg diben-
zyline, and C. illustrates that the reactive hyperaemia has prac-
tically disappeared after infusion of 30 mgr/kg dibenzyline. 
Further analysis of the reactive hyperaemia in this experiment 
is demonstrated in Fig.3 (p.37).If an increase in the pulsatile flow 
to twice the original value is taken as 100% reactive hyperaemia, 
the values were calculated as follows: 
I. At 0 min. at the start of the dibenzyline infusion: 
46 - 24 , P.F.S.: 24 mm M.P.F.S.: 46 mm R.H. . 100 = 91% ( in 
percentages of the original value). 34 
II. At 15 min.: R.H.• 50 - 34 . 100 • 47% 
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III. Thus, the reactive hyperaemia Is reduced to 20% with 
15 mgr/kg dibenzyline. Only with twice that amount there-
active hyperaemia is reduced to near zero with 2%. 
Further on in this experiment the following values for re-
active hyperaemia were calculated: 
. 20 - 19 IV. 10 Min. after E. col1: R.H.= . 100 = 5% 
v. 
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With decreasing values for the flow and therefore for the 
M.P.F.S. and P.F.S., the quotient becomes less reliable and 
thus the R.H. percentage also: 
9 - 8 30 Min. after start E. coli: R.H.• 100 10% 
8 
VI. 20 Min. after start traslcor lnfusion:R.H.- 15 - 14 .100= 7% 
14 
VII. 45 Min. after start trasicor infuslon:R.H. 15 - 14 .100= 7% 
14 
1,5 mgr/kg in. 
VII. 90 Min. after start trasicor infuslon:R.H.- 15 - 14.100= 7% 
14 
36 
3,0 mqrjkg in. 
w 
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dib. 
M.P.F.S. 46 50 49 
(mm) 
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dib. in. 
43 43 
35 35 
20 20 
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45 43 
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Fig.3. Decrease of reactive hyperaemia during biphasic blockade with 30 mgr/kg dibenzyline 
and 3 mgr/kg trasicor in endotoxin shock (5 mgr/kg). 
Discussion and conclusions: 
It can be assumed that the infusion of massive amounlts of a vasodi-
latory substance like dibenzyline, as is the case in this experi-
ment, will lead to a decrease of further expansibility or loss of 
'!"est compliance of the vessel, expressed in a decreased reactive 
hyperaemia. 
Fig. 3 illustrates that the reactive hyperaemia before diben-
zyline is clear enough, but that it is still thereafter infusion 
of 15 mgr/ kg. 
It is only after another dose, far above the accepted maximum, 
30 mgr/kg bodyweight in total, that reactive hyperaemia practical-
ly disappears. 
These results explain why chasing a hi~h dose of dibenzyl ine was 
thought necessary in our further experiments: 15 mgr/kg dibenzyline, 
although many times the accepted maximum dose of literature,still 
does not fully abolish the reactive hyperaemia phenomenon and 
therefore the faculty of the vessels to dilate even further. 
If one considers a vasodilatory substance to have a maximum 
dose, apart from the lethal and toxic effects, it should be the 
dose beyond which no 
Apparently that dose 
further dilatation is possible. 
is not 
which is much more than the 
yet even reached with 15 mgr/kg, 
accepted dose of 3,5 mgr/kg (68,69). 
After addition of trasicor, the reactive hyperaemia does not in-
crease but is constant at a low level. 
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C. 2-5 Estimation of circulating endotoxin 
Objective: To test the experimental model used, it was thought 
necessary to verify if endotoxin could be determined in 
the circulation. 
Materials and methods: Two indirect tests, as described in chap-
ter B. 2-1-1-4, were used in a small num-
ber of experiments with 5 mgr/kg bodyweight endotoxin injection. 
The L i m u 1 u s 1 y s a t e t e s t was performed three ti-
mes in 4 experiments (2 after dibenzyline premedication, 
2 without treatment). 
Blood sample 1 was taken immediately after endotoxin injection, 
blood sample 2 in the first phase of shock, 20 min. after endo-
toxin injection and blood sample 3 in the second phase of shock, 
120 min. after endotoxin injection. 
In a preliminary test blood samples taken before endotoxin injec-
tion, proved endotoxin-free. Results are given as+, ++and+++ 
ratings, according to the time needed to give a positive test 
(formation of a solid gel of the plasma to be tested with the 
limulus lysate) (Table 2). 
The A c t n o m y c i n 0 - t e s t was performed in two ex-
periments (1 with biphasic blockade, 1 without treatment). 
Blood samples were taken at the same moments during the shock 
procedure as in the Limulus lysate test. 
The activity of a standard preparation endotoxin with a L. D. 50% 
corresponded arbitrarily with 10 calculation units. 
The results are compared with this standard preparation and ex-
pressed in these calculation units (Table 2). 
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-------------------i Sample 1 Sample 2 Sample 3 Survival/ A. L!MULUS LYSATE TEST death 
Exp. 1 
Oibenzyline 
premedication 
Exp. 2 
Without treatment 
Exp. 3 
Oibenzyline 
premedication 
Exp. 4 
Without treatment 
B. ACTINOMYCIN 0-TEST 
Exp. 1 
Biphasic blockade 
+++ 
++ 
++ 
+++ 
(Oibenzyline and trasicor 40 U 
Exp. 2 
Without treatment 8 ,2 u 
+++ 
++ 
++ 
+++ 
85 u 
25 u 
++ 
++ 
++ 
++ 
59 u 
6, 2 u 
survived 
>14 days 
died 
survived 
>14 days 
died 
died 
died 
Table 2. Results of the Limulus lysate test and the Actinomycin 
0-test on circulating endotoxin (5 mgr/kg bodyweight) in 
endotoxin shock experiments. 
40 
Discussion and conclusions: 
The Limulus lysate test demonstrated, that in these experiments 
circulating endotoxin could be detected up till 2 hours after in-
jection.This was confirmed in the two experiments with the Acti-
nomycin D-test in mice. 
Although the level 20 min. after endotoxin injection was mostly 
higher than after 2 hrs., the latter level gave no indication of 
survival prognosis. 
C. 2-6 Estimation of plasma catecholamine levels 
Objective: To find support for the catecholamine hypothesis, as 
discussed in chapters B. 2-3 and B. 2-4, it seemed neces-
sary to verify in our experimental set up if an increase of cate-
cholamine levels could be detected after endotoxin injection. 
Materials and methods: Catecholamine levels were measured in 4 ex-
periments, according to the techniques as de-
veloped by Anton and Sayre (3) and Laverty (59). 
The blood samp~es were taken before endotoxin injection (a), as 
a control of the normal value in that experiment, and in the 
second phase of shock, 1~ hr. after endotoxin injection (b). 
In all experiments 5 mgr/kg bodyweight endotoxin was injected. 
Two experiments were performed with biphasic blockade, one with 
dibenzyline premedication and one with combined simultaneous 
blockade, all paired with an untreated control animal (Table 3). 
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Epinephrine Norepinephrine Su'rvival/ 
"gr/1 plasma "gr/1 plasma death 
Exp. 1 
Di benzyl i ne a: 2, 2 4,7 died 
premedication b: 3,3 8,7 
Control animal a: 1 , 4 0,8 survived 
b: 2,2 0, 5 >14 days 
Exp. 2 
Combined biphasic a: 0,67 0, 7 5 survived 
blockade b: 1 ,58 4,94 >14 days 
(dibenzyline and trasicor) 
Control animal a: 0,44 0,94 died 
b: 7,91 4,59 
Exp. 3 
Combined simultaneous a: 0, 9 0,6 died 
blockade b: 3 ,8 8,5 
(premedication) 
Control animal a: 1,1 1 ,3 survived 
b: 3,4 1,5 >14 days 
Table 3. Results of plasma catecholamine determinations in endo-
toxin shock experiments (5 mgr/kg bodyweight). 
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Conclusions: 
Increased plasma epinephrine levels were detected after endotoxin 
injection in all animals tested; both in adrenergically blocked 
and untreated animals. 
The two surviving control animals had no increase in norepine-
phrine levels, the other animals did have an increase in norepine-
phrine levels. 
This small amount of data seems to endorse the validity of the 
catecholamine hypothesis in our experimental model. In this 
respect our study is comparable to other experimental studies as 
described in literature 
Summary and conclusions of the pilot study: 
Premedication with dibenzyline, as well as biphasic alpha-beta-
blockade with dibenzyline and trasicor,both in a high dose, clearly 
improved survival. No other treatment improved survival. 
It was shown that the high dose of dibenzyline used ( 15 mgr/kg 
bodyweight) did not even give maximum vasodilatation. It can be 
concluded that 15 mgr/kg dibenzyline is still not the maximum 
dose. It could be demonstrated that endotoxin circulated for at 
least 2 hrs. after injection. 
This observation is taken as another argument in favour of high 
dosage of any therapy to protect the circulation for a prolonged 
period of time against the endotoxin effects. The increase of 
epinephrine levels found, might support the catecholamine hypo-
thesis. 
The results of the pilot study justified further more systematic 
analysis of the working hypothesis in the following investigation. 
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C. 3 ~1ain study 
C. 3-1 Objectives: 
As a result of the pilot study, the principal objective of the 
main investigation was to analyse more extensively in a standar-
dized model the effects of biphasic combined alpha-beta-blockade 
on canine endotoxin shock. 
As comparison,alternative treatment schedules would be studied as 
well. Data on survival, haemodynamics, biochemics and histology 
were compiled and subjected to statistical analysis. 
C. 3-2 Materials and methods 
The experimental animal: Experiments were performed on beagles, 
weighing from 10 to 20 kg. 
Endotoxin: This was injected i.v. in 1 min. suspended in 25 ml 
Ringer's solution. A number of batches of Endotoxin 
coli was used, codenumber 127:88, Difco Laboratories, Detroit. 
Anaesthesia: After induction with 30 mgr/kg bodyweight Nembutal 
and endotracheal intubation, a light o2-N 20-Fluo-
thane narcosis was maintained throughout the experiments. The 
testing of various parameters was only started when spontaneous 
respiration occurred, which was maintained during the whole ex-
periment. 
Infusions and timing: All animals, treated and untreated alike, 
received the same amount of fluid, in the 
following time schedule: 
1. A 500 ml Ringer's solution was given before the injection of en-
dotoxin , in an infusion time of 12 hrs. In case of pretreat-
ment the anti-adrenergic compound(s) were dissolved in this 
500 ml Ringer's solution. 
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In cases without premedication, the Ringer's solution was given 
as well, but without adjunctive chemical compounds. 
2. Endotoxin injection followed 15 min. after the end of the in-
fusions mentioned above,for both the treated and untreated 
cases alike. 
3. After endotoxin injection, 200 ml Ringer's solution was infu:sed 
over 30 min. This solution did not contain any adjunctive me-
dication in treated and untreated cases alike. 
4. After these 30 min. postendotoxin,infusion wasstartedof 500ml 
Ringer's solution with an infusion time of 1! hrs. When medi-
cation was given during this period (in biphasic blockade or 
monophasic trasicor) the anti-adreRergic compound(s) were dis-
solved in this 500 ml Ringer's solution. 
5. Longer surviving animals received 1500 ml Ringer's solution 
i.v. with an infusion time of 24 hrs., starting the first day 
after the experiment, unless oral fluid intake was possible. 
Thus, all animals in all experiments received the same amounts of 
fluid, including the control animals which were injected with en-
dotoxin without anti-adrenergic treatment, and also including the 
animals which received anti-adrenergic treatment without endo-
toxin, as a check on the effects of the treatment as such. 
In all animals subjected to endotoxin shock, the only variable 
was therefore the addition or omission of the anti-adrenergic 
compounds to be tested. 
Medications: The anti-adrenergics used were dibenzyline in a dose 
of 15 mgr/kg bodyweight and trasicor in a dose of 
1,5 mgr/kg bodyweight. The choice of the dibenzyline and trasicor 
dose was based on the results in the pilot study. 
Dibenzyline was always given as premedication and was suspended 
in the first 500 ml Ringer's solution. Trasicor was either given 
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as medication after endotoxin, being suspended in the last 500ml 
Ringer's solution, or given as premedication together with diben-
zyline in the first 500 ml Ringer's solution. 
All animals received 2.000.000 U penicillin and 1 gr streptomycin/ 
day, for 7 days or until death, starting on the day of the ex-
periment. 
Types of experiments: Five different types of experiments were 
carried out: 
1. Combined biphasic adrenergic blockade without endotoxin (C 3-3). 
2. Endotoxin shock without treatment (C 3-4). 
3. Monophasic adrenergic blockade before or after endotoxin 
administration (C 3-5). 
4. Combined simultaneous adrenergic blockade before endotoxin 
administration (C 3-6). 
5. Combined biphasic adrenergic blockade before and after endo-
toxin administration (C 3-7). 
Survival: Survival was recorded in hours after endotoxin injection. 
Survival for more than 2 weeks was considered indefinite. 
Blood pressure measurements: The pulsatile blood pressure was con-
tinuously recorded in all experiments 
via an intra-arterial catheter, situated in the femoral artery. 
The pressure recordings were calibrated in such a way that 
100 mm Hg corresponded with 2 em of the record sheets of the Ele-
ma-recorder. 
Average values of the systolic blood pressures during the shock 
procedure (S.B.P.) in the experimental animals of the various 
groups, were calculated at 10 min. intervals. In some experiments 
the mean of systolic and diastolic blood pressure (M.B.P.) was 
registrated and here also average values for these experiments 
were calculated (C 3-7-1). 
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Trends in the changes of arterial blood pressure were analyzed. 
Blood flow measurements: The transflow 600 1'Scalar''apparatus was 
used with the corresponding transflow 
600 peri-vascular electromagnetic flowprobes ''E.F.M.'. 
The probes were fitted around the (other) femoral artery of the 
experimental animal. Both pulsatile and mean flow were registrated. 
The deflections resulting from changes in bloorl flow were visuali-
lized on the Elema-recorder. The sensitivity of the recorder was 
such that an output of 0,3 volt was chosen for the calibration. 
The pulsatile flow output corresponded with 1,5 em deflection on 
the Elema-recorder,the mean flow output with a choice of 2,5; 4,5 
or 5 cm.All measurements were done with 1'acute'' (not previously 
implanted) flowprobes. This made frequent 0-controls necessary. 
Registrations which were unreliable were discarded from-· the study. 
Average values of the mean flow during the shock procedure in the 
experimental animals of the various groups were calculated at 10 min. 
intervals. Trends in the changes in the mean flow were analyzed. 
Peripheral resistance: The formula used for calculating the total 
peripheral resistance (T.P.R.) was (37,113): 
T. P.R. 
P - 2 0 ( mm H g) 
F 
P = blood pressure 
F blood flow 
20 mm Hg the critical closing 
pressure in dogs (37) 
Duration of the blood flow and -pressure registration: 
These parameters were continuously registrated on the Elema-recor-
der throughout the duration of the experiments up till 2! hrs. 
after endotoxin injection. 
This period was chosen because at 2 hrs. after endotoxin injec-
tion the shock pattern is well into the second phase and usually 
in a steady state. 
The 2} hrs. registration period was also based on information in 
literature by Swan (103), who did registrations until death in 
experimental endotoxin shock and found that parameters in the 
later shock phase only change in the last 15 min. 
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In a few experiments (C 3-9) registration was continued up till 
6 hrs. after endotoxin, to check whether in this experimental 
model any changes in the trend of blood pressure and -flow occur-
red later on. 
Registrations longer than approximately 6 hrs. were not consider-
ed usefull, because measurements might become inexact. 
Heart rates: The influence of adrenergic blockades on the heart 
rates of the dogs, subjected to endotoxin shock were 
analyzed (C.3-4 to C.3-8). 
Average values of the heart rates were calculated at 10 min. in-
tervals, and trends in increase or decrease of the rates analyzed. 
Biochemical data: Serum levels of creatinine, urea, alc.phospha-
tase, bilirubin, SGOT and SGPT were determined 
before endotoxin injection,at the end of the period of measureme.nt 
and,in case of survival, 20 hrs. after endotoxin injection. 
On statistical analysis of these biochemical data they were found 
not to correlate with the severity of shock. 
They are for that reason not included in the description of ex-
perimental results. 
Blood gases were analyzed with the Astrup method, at regular in-
tervals throughout the period of measurement. 
Values for pH and HC0 3 were analyzed for the experiments with 
combined biphasic blockade and endotoxin shock without treatment. 
Results are described in chapter C. 3-7-3. 
Autopsy findings: 
In the non-surviving animals autopsy was performed. 
M a c r o s c o p i c a 1 1 y, the characteristic haemorrhagic 
necrosis of the bowel mucosa (68,69) and pulmonary oedema were 
rated as follows: 
0 no changes 
+ ~ light 
++ moderate 
+++ ~ severe changes 
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M i c r o s c o p i c a 1 1 y , the lungs, the small bowel, the 
colon and the kidney were specifically examined. 
The changes found were rated as follows: 
Lung: 0 = norma 1 
+ mi 1 d congestion 
++ severe congestion 
+++ congestion + thrombus 
++++ congestion + haemorrhage + tissue damage 
Small bowel: 
0 = normal 
+ mild congestion 
++ severe congestion 
+++ = congestion + superficial mucosal damage 
++++ congestion + severe mucosal loss 
Colon: as small bowel 
Kidney: 0, +, ++, +++. ++++: increasing severity of congestion 
The macroscopic findings will be described in the sub-chapters 
on the various groups of experiments. 
The microscopic findings were compiled for all groups and will be 
described in chapter C. 3-7-3. 
Statistical analysis of parameters: Shock parameters of the ex-
perimental animals in the 
various groups were compiled. The averages with standard devia-
tion (S.D.) of (systolic) blood pressure, (mean) blood flow and 
peripheral resistance were calculated for the whole group at 
fixed moments during the shock procedure. 
Reliable flow measurements could not be obtained in all experi-
ments. Most parameters were statistically analyzed, using one of the 
following tests: the matched-pairs signed Rank test, the Mann-
Whitney-U test, the Chi-square test , the test against trend in 
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related samples, the Binomial test and the Yates-Cochran test 
(55,56,100;101). 
All tests were performed at a significance level of alpha=0,05. 
Most tests were two sidedly performed. 
For this further analysis, some groups of experiments were com-
bined and the effect of various dosages of endotoxin on the shock 
pattern were compared. 
Survival differences in treated and untreated animals were com-
pared for the various dosages of endotoxin and the various forms 
of anti-adrenergic treatment. 
The influence on blood flow, blood pressure and heart rates of 
anti-adrenergic blockades was analyzed. 
In the combined groups, effects of adrenergic blockade on bio-
chemical data and autopsy findings were estimated. 
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C. 3-3 Biphasic adrenergic blockade without endotoxin 
Objective: To check the effect of dibenzyline and trasicor on 
haemodynamics and survival in the experimental animal 
without endotoxin. 
Materials and methods: Seven dogs were treated with a biphasic 
blockade, applying 15 mgr/kg bodyweight 
dibenzyline and 1,5 mgr/kg trasicor, given in the same time re-
lations as used inthe experiments with endotoxin. 
Infusions and timing in these and all following experiments 
were described in chapter C. 3-2. 
Results: 
1. Survival: All 7 dogs survived >14 days. 
2. Systolic blood pressure (S.B.P.): Table·4 gives the average 
values of the systolic blood pressures with S.D. 
This is graphically illustrated in Fig. 4. 
During dibenzyline infusion the (average) S.B.P. decreased from 
176 mm Hg + 109 mm Hg. Trasicor infusion gave an initial in-
crease of the S.B.P. to 130 mm Hg at 35 min., followed by a 
decrease to 102 mm Hg at 40 min. and 106 mm Hg at 130 min. 
3. Mean blood flow: Table 5 gives the average values of the mean 
blood flow in this group. This is graphically illustrated in 
Fig. 5. During dibenzyline infusion the (average) blood flow 
increased from 101 ml/min. + 115 ml(min. Trasicor leads to 
some flow decrease: from 115 ml/min. + 92 ml/min. 
4. Peripheral resistance (P.R.): Table 6 gives the values and 
Fig. 6 is the graphic illustration of the P.R. in this group. 
During dibenzyline infusion the (average) P.R. decreased from 
1,26 mm Hg/min./ml + 0,48 mm Hg/min./ml. During trasicor in-
fusion it increased again to 0,82 mm Hg/min./ml. 
5. Autopsy findings: No autopsies were performed, all animals 
surviving the adrenergic blockade without endotoxin. 
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adrenergic blockade without endotoxin. 
blood pressure + S.D. 
DIBENZYLINE INFUSION TRASICOR INFUSION 
Time Time 
in min. S.B.P. S.D. in min. S.B.P. 
Start )+ - 110 1 76, 14 22,35 0 109,42 dibenzyline - 100 165,85 27,90 10 108,71 
90 159,85 25,70 Start 20 108,00 
- so 152,57 28,80 trasicor )-> 30 108,00 70 145,14 26,39 35 130,14 
- 60 137,00 30,03 40 102,14 
50 130,85 26,06 50 101 ,42 
- 40 124,42 24,72 60 99,85 
30 117185 22,13 70 101,00 
End )+ - 20 115,28 22,96 80 101,14 dibenzyline 10 112,71 27,21 90 101,71 
0 109,42 27,26 100 102, DO 
End 110 1 03 1 18 
trasicor }->- 120 1 OS ,42 
130 106,28 
Table 4.Biphasic adrenergic blockade without endotoxin. 
n = 7. S.B.P. in mm Hg. 
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S.D 
27,26 
26,49 
27,83 
27,83 
32,59 
21,55 
22,52 
21 '73 
23,05 
22,56 
23,29 
25,61 
27,59 
26,17 
25,43 
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Fig. 5. Biphasic adrenergic blockade without endotoxin. 
Blood flow + S.D. 
DIBENZYLINE INFUSION TRASICOR INFUSION 
Time Blood Time Blood 
in min. flow S.D. in min. flow S.D. 
Start ·> - 110 101,24 22,24 0 115,25 30,41 
dibenzyl ine l - 100 101,43 21,25 10 119,57 35,71 
- 90 112,40 22,31 Start l 20 115' 56 32,68 
- 80 112,91 21,33 30 113,41 32,67 
- 70 115,16 23,46 trasicor -)- 35 118,89 42,35 
- 60 118,62 27,59 40 83 '71 31,50 
- 50 118' 53 32,78 50 90,41 34,10 
- 40 119,77 34,47 60 87,55 37,76 
- 30 119,56 29,13 70 87,84 38,24 
End - 20 122,25 30,51 80 85,77 38,42 
dibenzyl ine }+ - 10 118,96 29,31 90 86,37 38,38 
0 115,25 30,41 100 87,60 38,81 
110 89,68 37,09 
End . l+ 120 92,80 38,84 tras1cor 130 92,37 36,67 
Table 5. Biphasic adrenergic blockade without endotoxin. 
n ; 7. Blood flow in ml/min. 
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Fig. 6. Biphasic adrenergic blockade 
Peripheral resistance ~ s. D. 
without endotoxin. 
D!BENZYLIN E INFUSION TRASICOR INFUSION 
Time Time 
in min. p. R. S.D. in min. P.R. 
Start + - 110 1,26 0,17 0 0,48 
dibenzyline} - 100 0,97 0,41 10 0,46 
- 90 1,00 0,14 Start 20 0,49 
- 80 0,94 0,14 trasicor }-> 30 0,62 
- 70 0,85 0114 35 0,74 
- 60 0,76 0,13 40 0,73 
- 50 0,72 0,14 50 0,77 
- 40 0,64 0,12 60 0,76 
- 30 0,58 0,11 70 0,76 
End - 20 0,50 0,11 so 0,76 
d i benzyl in e)+ 
- 10 0,47 0,18 90 0,78 
0 0,48 0,21 100 0,81 
End 110 0,79 
trasicor }+ 120 0,81 130 0,81 
140 0,82 
Table 6. Biphasic adrenergic blockade without endotoxin. 
n = 7. P.R. in mm Hg/min./ml. 
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S.D. 
0,21 
0,21 
0,21 
0,21 
0,24 
0,32 
0,31 
0,45 
0,47 
0,46 
0,50 
0,53 
0,53 
0,53 
0,53 
0,52 
Discussion and conclusions: 
Blood pressure and peripheral resistance decrease and blood flow 
increases during dibenzyline infusion. 
In the trasicor phase the flow is slightly lower and the periphe-
ral resistance slightly higher in comparison with the dibenzyline 
phase. 
Anti-adrenergic medication in high dose in itself was not harm-
ful to the experimental animal. 
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C. 3-4 Endotoxin shock without treatment 
Objective: Evaluation of shock parameters in untreated animals, 
subjected to endotoxin shock. Verification in our model 
of the biphasic shock pattern, as described in literature. Subse-
quent comparison of these parameters with the shock pattern of 
treated animals. 
Materials and methods: Average values of systolic blood pressure 
with standard deviation (S.D.) was calculated 
in a group of 25 experiments, in which 5 mgr/kg bodyweight endotoxin 
was given. The trends (increasing or decreasing)of the average sys-
tolic blood pressure after endotoxin was investigated in the follow-
ing intervals: 0->- 5 min., 5 ->-10 min. ,10 ->-15 min. and 60 ->-140 min. 
after endotoxin injection. In the intervals 0 -r.5 min, and 5 + 10 min., 
the Wilcoxon matched-pairs signed ranks test was used (56). In the in-
tervals after 10 min. a test in related samples was used (55),all two 
sidedly performed at a level of significance of alpha=0,05.Reliable 
flow measurements could be obtained in a group of 14 of these experiments. 
Average values of the mean blood flow in this group were calculated. 
The trend of the blood flow after endotoxin injection was investiga-
ted in the same time relations as the blood pressure trends,apply-
ing the same statistical tests (alpha=0,05).Peripheral resistance 
was also calculated for these experiments.The average values of the 
heart rates were calculated at 10 min. intervals with S.D. Shock 
parameters of surviving and non-surviving experimental animals 
were taken together. 
Results: 
1. Survival: Of the 25 dogs, 16 died and 9 survived >14 days. 
2. Systolic blood pressure (S.B.P.): Table 7 gives the average 
values for the systolic blood pressure of the 25 cases with 
S.D. Those values are graphically illustrated in Fig. 7. 
After endotoxin the S.B.P. decreased within 10 min. from 
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174 mm Hg + 66 mm Hg. A recovery to 102 mm Hg at 50 min. was 
followed by a further decrease to 68 mm Hg at 140 min. 
Trends of the blood pressure: from 0 + 5 min. after endotoxin 
injection, a significantly decreasing trend (S.D.T.) was found. 
From 5->- 10 min. after endotoxin injection no significant 
trend(N.S.T.) was found.The trend in blood pressure from 10 + 
50 min. was significantly increasing (S.J.T.) and from 60 + 
140 min. significantly decreasing (S.D.T.). (Fig. 28,p. 104). 
3. Mean blood flow: Table 8 gives the average values of the mean 
blood flow in the group of 14 experiments in which reliable 
flow measurements were obtained during the whole procedure. 
Fig. 8 is the graphic illustration of the same. 
After endotoxin injection the flow decreased within 10 min. 
from 124 ml/min. + 14 ml/min. A recovery to 61 ml/min. at 
50 min. was followed by a further decrease to 32 ml/min. at 
140 min. 
Trends in mean blood flow: from 0 + 5 min after endotoxin in-
jection: S.O.T.; 5 + 10 min.: N.S.T.; 10 +50 min.: S.J.T. 
and from 50+ 130 min. after endotoxin injection S.O.T. (Fig.32). 
4. Peripheral resistance: Table 9 gives the values in numbers 
and Fig. 9 in graphic form. 
After endotoxin injection the P.R. increases within 10 min. 
from 1,05 mm Hg/min./ml + 5,09 mm Hg/min./ml. 
A decrease to 1,54 mm Hg/min./ml at 50 min. was followed by 
another increase to 1,66 mm Hg/min./ml at 140 min. 
5. Heart rates: The following average values with S.D. are rele-
vant: at T =-120: 161 beat.s/min. (S.D. :20); at T = 0: 164 
beats/min. (S.D.:29); at T = 120: 156 beats/min. (S.D.:29). 
6. Autopsy findings: All non-surviving animals in this group 
showed intestinal haemorrhagic necrosis, mostly rated as severe 
lesions. Four animals had light pulmonary changes. 
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Fig. 7. Endotoxin shock (5 mgr/kg) without treatment. 
Systolic blood pressure + S.D. 
PRE-ENDOTOXIN POSTENDOTOXIN 
Time Time 
in min. S.B.P. S.D. in min. S.B.P. S.D. 
- 110 174165 27181 Endotoxin + 0 174134 29,58 
- 100 174111 28158 injection } 5 73,03 30129 
- 90 174119 28150 10 66,57 25,09 
- 80 174146 29,01 15 72176 32,53 
70 174,26 28191 20 78,19 35,82 
- 60 173,53 29,11 30 89,11 40,56 
50 173,38 28,60 40 98,42 40,25 
40 172,88 28,62 50 102,53 38,61 
30 173,38 29,38 60 98,73 35,85 
- 20 173184 29,38 70 94,80 34,83 
Endotoxin 10 173,42 29,44 80 92,11 34,23 
injection }-> 0 174,34 29,58 90 87,23 31 ,88 
100 81,73 29,13 
110 77,34 28,27 
120 73,20 29,49 
130 71,63 30,14 
140 68,65 31,50 
150 69,73 32,78 
Table 7. Endotoxin shock (5 mgr/kg) without treatment. 
58 n = 25. S.B.P. in rrrn Hg. 
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Fig. B. Endotoxin shock (5 mgr/kg) without treatment. 
Blood flow+ S.D. 
PRE-ENDOTOXIN POSTENDOTOXIN 
Time Blood Time Blood 
in min. flow S.D. in mi·n. flow S.D. 
- 110 1 OS, 90 36,84 Endotoxi nf' 0 124,03 39,38 
- 100 109,22 36,11 injection 5 15,09 9,51 
-
90 110,63 29,14 10 14,13 11 ,64 
- 80 113,68 33,65 15 18,23 12,04 
- 70 112,74 29,10 20 19,08 11 143 
- 60 115,68 24,60 30 37,64 20,91 
-
50 115' 79 24,30 40 52,44 33,38 
- 40 112,38 26,61 50 61,59 42,35 
- 30 110' 76 28,66 60 57,31 38,85 
- 20 114,49 28,19 70 57,34 38,57 Endotoxin 
-
10 122,79 35,53 80 51,43 35,82 injection}+ 0 124,03 39,38 90 51 ,32 35,50 
100 44,59 27,07 
110 41,16 21 ,81 
120 39,09 23,47 
130 35,73 20,49 
140 32,36 19,95 
Table 8. Endotoxin shock (5 mgr/kg) without treatment. 
n = 14. Blood flow in ml/min. 
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IT!m. l"g.mi n.mlj 
6.4 
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4,8 
4.0 
-120 
Fig. 9. Endotoxin 
-j;O 
shock (5 
E 
0 
0 
mgr/kg) 
60 120 
without treatment. 
Peripheral resistance + S.D. 
PRE-ENDOTOXIN POSTENDOTOXIN 
Time Time 
in min. p. R. S.D. in min. P.R. 
- 110 1,33 0,33 Endotoxin1-> 0 1,05 
- 100 1,28 0,34 injection 5 3,54 
90 1 ,24 0,25 10 5,09 
80 1,14 0,25 15 2,54 
70 1 , 1 7 0,25 20 2,87 
- 60 1 , 15 0,29 30 1,96 
50 1,14 0,26 40 1 ,86 
- 40 1 ,10 0,29 50 1,54 
30 1,14 0,28 60 1,64 
- 20 1 1 15 0,30 70 1, 75 
Endotoxin 10 1,08 0,25 80 1 151 injection}+ 0 1,05 0,26 90 1,58 
100 L17 
110 1,31 
120 1 ,31 
130 1,61 
140 1,66 
Table 9. Endotoxin shock (5 mgr/kg) without treatment. 
n = 14. p. R. in mm Hg/mi n. /ml. 
60 
time 
in min. 
S.D. 
0,26 
1 ,39 
3,56 
1,36 
2,79 
1,13 
L42 
0,86 
1,03 
1,18 
0,69 
1,00 
0,47 
0,61 
0,66 
1,18 
1,17 
Discussion: 
5 Mgr/kg bodyweight endotoxin appeared not to be a L.D. 95%, as 
suggested in literature (18,106). 
The biphasic pattern of blood pressure in experimental endotoxin 
shock was confirmed, as illustrated in Fig. 7. 
Fig. 8 demonstrates what happens to blood flow in the femoral 
artery: the decrease immediately after endotoxin injection (the 
first phase) is steep. 
A recovery follows and then the slower progressive decrease of 
the second phase sets in. 
Blood flow in the femoral artery therefore also follows a bipha-
sic pattern and has an inverse relationship with peripheral re-
sistance (Fig. 9). 
At autopsy the intestinal haemorrhagic necrosis, described in 
literature, was confirmed (66,67). 
Conclusion: 
Endotoxin shock in dogs has a biphasic pattern: immediately after 
endotoxin injection a steep decrease of blood pressure and blood 
flow is seen, a recovery phase setting in after 5 to 10 min. 
A second blood pressure-and blood flow decrease starts approxi-
mately 60 min. after endotoxin injection. 
These trends in the biphasic pattern of blood pressure and blood 
flow proved statistically significant. 
The L.D. 95% of a shock model in which 5 mgr/kg bodyweight Endo-
toxin coli (0127:88 Difco) is applied, appears questionable 
(c. 3-8). 
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C. 3-5 Monophasic blockade 
C. 3-5-1 Dibenzyline premedication 
Objective: To test the influence of premedication with dibenzy-
line in a high dose on the pattern of endotoxin shock. 
Materials and methods: Five paired experiments were done with en-
dotoxin shock, applying 5 mgr/kg bodyweight 
endotoxin, batchnumber 581374-2. 
In each paired experiment, one animal was premedicated with 
15 mgr/kg bodyweight dibenzyline and the other, which functioned 
as control, was not. 
All other experimental conditions (endotoxin, infusions, timing 
etc.) were the same in these paired experiments. 
Shock parametersof surviving and non-surviving animals in each 
group, treated and untreated alike, were taken together. 
Blood pressure, blood flow and peripheral resistance are presen-
ted in this chapter as far as the dibenzyline premedicated group 
is concerned. The data of the untreated animals in these experi-
ments were combined with those of other untreated series (C. 3"5-2, 
C. 3-6 etc.) to form a compiled controlgroup (C 3-4 and C. 3-7-3). 
By applying the Mann-Whitney-U test, it was investigated whether 
there were moments when the blood flow of treated dogs showed a 
statistically significant difference from the flow of untreated 
dogs (5 dogs with dibenzyline pretreatment against the compiled 
group of 14 untreated dogs). 
The trends of the heart rates in the dibenzyline infusion period 
(T= - 120 -> T = 0 min.) and in the period after endotoxin (T = 0+ 
T = 120 min.)were analyzed with a test against trend in related 
samples (alpha=0,05). 
The heart rates of the dibenzyline premedicated animals at 
T = 0 and T = 120 were compared with those in a compiled control-
group of 25 untreated dogs, applying the Mann-Whitney-U test 
( two sidedly performed, alpha = 0,05). 
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Results: 
1. Survival: In the treated and untreated group alike, 3 out of 
5 dogs survived >14 days. 
2. Systolic blood pressure: Table 10 gives the average values for 
the systolic blood pressure with S.D. of the treated group. 
Fig. 10 graphically illustrates these values. 
The S.B.P. at - 110 min. was 181 mm Hg, at 0 min. 119 mm Hg, at 
5 min. after endotoxin injection 86 mm Hg, at 50 min.lOl mm Hg 
and at 130 min. it was 74 mm Hg. 
3. Blood flow: Table 11 and Fig. 11 give the data. The flow in-
creased from 105 ml/min. at T = - 110 + 129 ml/min. at T = 0, 
at T = 130 it was 87 ml/min. 
In the statistical analysis, at the moments T = 0 and T = 50 
min. after endotoxin injection, no significant difference in 
flow was found. At all other moments the flow was significant-
ly higher in the treated dogs. 
4. Peripheral resistance: Table 
P.R. decreased fr.om 1,28 mm 
0,45 mm Hg/min./ml at T = D. 
12 and Fig. 12 give the data. The 
Hg/min./ml at T = - 110 + 
At T = 130 it was 0,38 mm Hg/mir)fml 
5. Heart rates: The following average values with S.D. are rele-
vant: at T =- 120: 168 beats/min. (S.D.: 36); at T = 0: 202 
beats/min. (S.D.: 43); at T = 120: 186 beats/min.(S.D. 27). 
In a compiled controlgroup these values were: at T = - 120 : 
161 beats/min. (S.D. : 20), at T = 0 : 164 beats/min. (S.D.: 
29); at T = 120 : 156 beats/min (S.D. : 29). 
In the T =-120 + T = 0 range, a significantly increasing trend 
was found in the dibenzyl ine premedicated group. 
In the T= 0 + T= 120 range no significant trend was found. 
On comparison of the heart rates in this group at T = 0 and 
T = 120 with the control group, it was found that at both moments 
the heart rate in dibenzyl ine premedicated animals was signifi-
cantly higher than in the controlgroup. 
6. Autopsy findings: At autopsy, the 2 non-surviving untreated 
animals showed severe intestinal lesions with haemorrhagic 
sludging of the mucosa, but no important pulmonary changes. 
One of the dibenzyline pretreated, non-surviving animals could 
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not be autopsied. The other had pulmonary atelectasis and no 
clear signs of intestinal lesions. 
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Fig. 10. Endotoxin shock (5 mg r/kg). Di benzyl ine premedication. 
Systolic blood pressure ~ S.D. 
PRE-ENDOTOXIN POSTENDOTOX IN 
Time Time 
in min. S.B.P. S.D. in min. S.B.P. S.D. 
Start -> 
- 110 181 '20 21,92 Endotoxin}+ 0 119,60 22,16 
dibenzyline 1 - 100 161,80 13,14 injection 5 86,60 22,24 
- 90 145,20 10,30 10 103,80 21,08 
- so 135,20 19,27 15 98,80 23,54 
- 70 134,40 19,15 20 102,40 26,23 
- 60 131 ,60 19,9S 30 103,00 26,73 
- 50 127,00 15,77 40 103,60 26,65 
- 40 123,60 13,06 50 101,00 25,37 
End - 30 124,60 13,08 60 97,80 21,64 
dibenzyline}-> - 20 123 '20 15,94 70 91,46 14,89 
En~otoxin }+ - 10 120,SO 21,27 so S9,80 15,46 0 119,60 22,16 90 87,80 16,48 1nJect1on 100 S6,00 14,10 
110 81,60 16,89 
120 81,00 16,91 
130 74,75 14,81 
Table 10. Endotoxin shock (5 mgr/kg).Dibenzyline premedication. 
n = 5. S. B. P. in mm H g. 
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Fig. 11. Endotoxin shock (5 mgr/kg). Dibenzyline premedication. 
Blood flow± S.D. 
PRE-ENDOTOXIN POSTENDOTOXIN 
Time Blood Time Blood 
in min. flow S.D. in min. flow S.D. 
Start } -> = 110 105,68 27,16 Endotoxin}-> 0 129,02 47,94 dibenzyline 100 118,57 31,50 injection 5 82,07 30,23 
- 90 126,85 32,69 10 79,16 30,80 
-
80 137,75 38,85 15 79,63 24,07 
- 70 148,79 41,85 20 84,18 24117 
- 60 154116 48,04 30 85,74 28,82 
- 50 138,83 48,49 40 89,55 29,51 
-
40 130,68 44,34 50 88,11 28,41 
End - 30 130,39 46,04 60 85,20 26,26 
dibenzyline }_:-. - 20 130,39 46,64 70 81,35 22,42 
~ndotoxin }-> - 10 131,03 50,88 80 78,28 22,72 0 129,02 47,94 90 81,57 28,30 1nJect1on 100 88,88 36,12 
110 90,33 39,49 
120 90,91 44,40 
130 87,36 37,72 
Table 11. Endotoxin shock (5 mgr/kg). Dibenzyline premedication. 
n = 5. Blood flow in ml/min. 
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Fig. 12. Endotoxin shock (5 mgr/kg). Dibenzyline premedication. 
Peripheral resistance± S.D. 
PRE-ENDOTOXIN POSTENDOTOXJN 
Time Time 
in min. p .R. S.D. in min. p. R. S.D. 
Start 1+ - 110 1,28 0,27 Endotoxin}+ 0 0,45 0,12 dibenzyline 
- 100 0,99 0,28 1 nJ ect10n 5 0,48 0,33 
- 90 0,80 Q 116 10 0,79 0,72 
- 80 0,67 0,17 15 0,62 0,33 
- 70 0,60 0,17 20 0,57 0,28 
- 60 0,55 0,17 30 0,55 0,29 
- 50 0,52 0,13 40 0,51 0,20 
- 40 0,49 0,12 50 0,51 0,19 
End - 30 0,48 0113 60 0,47 0,16 
dibenzylin~ }+ - 20 0,45 0,12 70 0,46 0,16 
- 10 0,45 0,11 so 0,46 0,18 
Endotoxin f' 0 0,45 0,12 90 0,41 0,17 
1nJect1on 100 0,38 0,17 
110 0,38 0,18 
120 0,39 0,17 
130 0,38 0,16 
Tab 1 e 12. Endotoxin shock ( 5 m g r I kg ) . D i ben zy 1 i ne premedication. 
n = 5. p. R. in mm Hg/min./ml. 
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Discussion: 
The difference in survival between dibenzyline pretreated and un-
treated cases was found not to be significant. 
The impact of the endotoxin shock procedure with regard to letha-
lity was small in this series. 
The potency of the endotoxin batch used might have been at fault. 
Survival data of control experiments (untreated animals) for all 
batches used are analyzed in chapter C. 3-8. 
During dibenzyline premedication, the blood pressure decreased 
while the blood flow increased. This means that the peripheral 
resistance decreases at the same time. 
After endotoxin, some decrease of blood pressure and - flow is 
seen , concomitant with some increase in peripheral resistance. 
On comparison with the pattern of untreated cases (C. 3-4, Fig. 7, 
8 and 9), the first shock phase seems to be less severe. 
In these dibenzyline premedicated animals no distinct secondary 
drop in blood flow was registrated after endotoxin. The flow 
remained in a steady state with no significant increase or decrease 
from the level shortly after endotoxin injection. 
The higher flow after endotoxin in this group as compared with 
controls was statistically significant for all moments of regi-
stration, with the exception of T = 0 and T = 50 min. after endo-
toxin injection. 
During dibenzyline infusion the heart rate increased significant-
ly and remained significantly higher after endotoxin injection. 
Conclusion: 
Dibenzyl ine premedication with 15 mgr/kg bodyweight prevented for 
a large part the severe drop in blood flow during the first, but 
also during the second phase of endotoxin shock. 
This blood flow was maintained with a high heart rate. 
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c. 3-5-2 Trasicor medication 
Objective: To be informed about the influence on survival and 
shock parameters of beta-blockade with trasicor, 
starting later on in the first, and directed to the second phase of 
shock, without premedicative alpha-blockade. 
Materials and methods: Four paired experiments were done with en-
dotoxin shock, applying 5 mgr/kg bodyweight 
endotoxin, batchnumber 582495-1. 
1,5 Mgr/kg bodyweight trasicor was given in the treated group, in-
fusion starting as medication 30 min. after endotoxin injection. 
As in the preceding chapter, statistical comparisons were made of 
differences in mean flow at fixed moments between the trasicor 
medicated animals and a compiled group of 14 untreated dogs (Mann-
Whitney-U test, one sidedly performed: alpha= 0,05). The trends 
and a vera ge va 1 u es of the heart rates were a 1 so statistic a 11 y ana 1 yz ed. 
Results: 
1. Survival: In the treated group 3 out of 4 dogs survived >14 
days and in the untreated group 2 out of 4 dogs. 
The difference in survival is not significant. 
2. Blood pressure: Table 13 presents the values for average sys-
tolic blood pressures in the treated group, with S.D. 
Fig. 13 is the graphic illustration of these values. 
The S.B.P. drops from 166 mm Hg to 99 mm Hg at 10 min. after 
endotoxin injection. 
A secondary increase to 120 mm Hg at 50 min. is followed by a 
decrease to 82 mm Hg at 140 min. 
3. Blood flow: Table 14 and Fig. 14 give the data. The flow in the 
treated dogs was lower from T = 15 min. after endotoxin injec-
tion, as compared with the untreated dogs, but differences were 
not statistically significant. It has to be taken into account 
that the treated group is small. 
The flow decreases from 78 ml/min. to 11 ml/min. at 15 min. 
after endotoxin injection. There is only a small secondary in-
crease to a maximum level of 27 ml/min. at 50 min. At 130 min. 
the level is approximately the same with 26 ml/min. 
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4. Peripheral resistance: Table 15 and Fig. 15 give the data. 
The P.R. increases after endotoxin injection from 1,4 mm Hg/ 
min./ml + 4,0 mm Hg/min./ml at 10 min., and remains at a high 
level of >2,7 mm Hg/min./ml. 
5. Heart rates: The following average values with S.D. are rele-
vant. At T =-120: 177 beats/min. (S.D.: 17); at T = 0:167 beats/ 
min. (S.D.: 11); at T = 120: 109 beats/min. (S.D.: 9). 
On statistical analysis in the T = 0 + T = 120 range no signi-
ficant trend was found. At T = 0 no significant difference be-
tween the heart rate of treated and untreated dogs was found 
(C. 3-4). At T = 120 the n·e.art rate of treated dogs was signi-
ficantly lower than the heart rate of untreated ones. 
6. Autopsy findings: At autopsy the non-surviving treated animal 
had no intestinal changes and a light pulmonary atelectasis. 
One of the non-surviving untreated animals showed severe, and 
the other light intestinal haemorrhagic lesions; no pulmonary 
changes were seen. 
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Fig. 13. Endotoxin shock (5 mgr/kg). Trasicor medication. 
Systolic blood pressure± S.D. 
PRE-ENDOTOXIN POSTENDOTOX IN 
Time Time 
in min. S. B. P. S.D. in min. S. B. P. 
- 120 162,00 19,66 Endotoxin}+ o 166,25 
- 110 163,25 21,89 injection 5 126,00 
- 100 161,00 15,34 10 99,75 
- 90 164,25 18,78 15 99,75 
- so 161,25 16,31 20 95,75 
- 70 168,50 26,40 Start _, 3 108,00 
- 60 168,75 27,14 trasicor
1 4 ~ 114' 50 
- 50 168,75 27,26 50 120,50 
- 40 169,00 29,56 60 119' 75 
- 30 167,25 26,27 70 111 125 
- 20 167,00 25,59 80 106,50 
Endotoxin } - 10 168,00 28,01 90 103,25 0 166,25 24,52 100 97,75 injection ->-
110 93,25 End 120 88,00 trasicor}+ 
130 85,50 
140 82,75 
Table 13. Endotoxin shock (5 mgr/kg). Trasicor medication. 
n = 4. S. B. P. in mm Hg. 
S.D. 
24,52 
13,44 
12,99 
12,99 
33,51 
31,14 
28,43 
23,47 
18,57 
14,66 
14,24 
11,95 
9,74 
9,91 
8,90 
10,24 
9,77 
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Fig. 14. Endotoxin shock (5 mgr/kg). Trasicor medication. 
Blood flow ~ S.D. 
PRE-ENDOTOXIN POSTENDOTOX!N 
Time Blood Time Blood 
in min. flow S.D. in min. flow 
- 110 90' 84 16,46 Endotoxin}-> o 78,95 
- 100 93,14 16,01 injection 5 27,89 
90 92,78 14,89 10 13,78 
80 89,68 11,53 15 11 '32 70 92,97 14,38 Start 20 11 , 3 2 60 90,65 12,27 trasicor}+ 30 15,29 so 88,50 8,87 40 21 , 56 
40 84,83 7,75 50 27,06 
30 81,98 6,69 60 25,39 
20 79,68 6,29 70 24,19 
Endotoxin } 10 78,04 6,82 so 21 , 9 2 
i nj ecti on _,. 0 78,95 9,36 90 23,67 
100 24,69 
110 23,21 End . +120 23,40 tras1corl 130 26,05 
Table 14. Endotoxin shock (5 mgr/kg). Trasicor medication. 
n = 4. Blood flowin ml/min. 
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time 
in min. 
S.D. 
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Fig. 15. Endotoxin shock (5 mgr/kg). Trasicor medication. 
Peripheral resistance ~ S.D. 
PRE-ENDOTOXIN POSTENDOTOXIN 
Time Time 
in min. P.R. S.D. in min. P.R. S.D. 
- 110 1,25 0,31 Endotoxin1+ 0 1,40 0,25 
-
100 1,25 0,28 injection 5 3,37 1,37 
90 1,26 0,26 10 4,04 1,13 
80 1,29 0,20 15 3,89 1,29 
70 1,25 0,20 Start 20 3,97 1,22 60 1,27 0,25 trasi cor}->- 30 3,77 1,43 50 1,29 0,21 40 3,09 1,42 
40 1,35 0,24 50 3,00 1,35 
30 1,37 a, 19 60 2,99 1, 38 
20 1,41 o;23. 70 2,87 1,49 
Endotoxin 1 0 1,44 o;zo 80 2,85 1,49 
injection1+ 0 1,40 0,25 90 3,10 1,52 
100 2,70 1,23 
End 110 3,08 1,42 
trasicor}+ 120 3,01 1, 76 
130 3,22 2,54 
Table 15. Endotoxin shock ( 5 mgr/kg). Trasicor medication. 
n = 4. P.R. in mm Hg/mi n. /ml . 
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Discussion: 
Differences in survival between trasicor treated and untreated 
animals are not statistically significant. 
Blood pressure is not influenced by trasicor in the first, nor in 
the second shock phase; the curve has the same biphasic pattern 
as in animals with untreated endotoxin shock. 
Trasicor medication, started later on in the first phase and di-
rected to the second phase of shock does not prevent the severe 
blood flow decline , characteristic for cases without dibenzyline 
premedication. 
The peripheral resistance increased after endotoxin injection and 
remained at a high level during trasicor medication. 
This is different from the situation without trasicor in untrea-
ted endotoxin shock, where the peripheral resistance after the 
initial sharp increase immediately after endotoxin injection has 
a tendency to decrease again later on (C. 3-4). 
Beta-blockade decreased heart rates during endotoxin shock, to a 
significantly lower level as compared with untreated cases. 
Conclusion: 
Beta-blockade 'in itself' gave no favourable change of the shock 
pattern. One reason for this lack of beneficial influence ofmono-
phasic beta-blockade directed to the second phase seems to be that 
the peripheral resistance increases after endotoxin injection and 
remains high during trasicor infusion. 
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C. 3-6 Combined simultaneous blockade (premedication) 
Objective: To investigate combined adrenergic blockade in which 
dibenzyline and trasicor were not given biphasically, 
but at the same time as premedication. 
Materials and methods: Ten paired experiments were done with en-
dotoxin shock, applying 5 mgr/kg bodyweight 
endotoxin, batchnumbers 573093-2, 581374-1 and 581374-2. 
15 Mgr/kg bodyweight dibenzyline and 1,5 mgr/kg bodyweight trasi-
cor were given together as premedication in the treated groups. 
Results: 
1. Survival: In the treated group 4 out of 10 dogs survived >14 
days. In the untreated group 1 dog died during intubation. 
2. 
Five out of the other 9 untreated dogs survived >14 days. 
Survival differences between treated and untreated animals were 
not statistically significant. 
Systolic blood pressure: The data of the S. B. P. are given in 
Table 16 and Fig. 16. The S. B. P. decreases from 106 mm Hg + 
57 mm Hg at 20 min. after endotoxin injection. At 60 min. the 
S. B. P. is 84 mm Hg and at 13 0 min. 62 mm Hg. 
3. Blood flow: The data of the blood flow are given in Table 17 
and Fig. 17. The blood flow has a low level at all moments 
after endotoxin injection, not surpassing 34 ml/min. 
4. Peripheral resistance: The data of the P.R. are given in Table 
18 and Fig. 18. The P.R. increases from 1,02 mm Hg/min./ml + 
2,83 mm Hg/min./ml at 5 min. after endotoxin injection and re-
mains thereafter at a higher level than before endotoxin in-
jection. 
5. Heart rates: The following average values with S.D. are rele-
vant: At T 0: 125 beats/min (S.D.: 26); at T = 120 : 124 
beats/min. (S.D. : 25). Therefore, in the T = 0 + T = 120 min. 
range no trend was found. 
6. Autopsy findings: Of the 4 non-surviving animals in the control-
group, three had signs of haemorrhagic intestinal necrosis at 
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autopsy, twice rated as moderate and once as severe. 
The animal without intestinal changes showed some atelectasis, 
the others had no pulmonary changes. 
Three of the 6 non-surviving treated animals presented intestinal 
lesions at autopsy, twice moderate and once severe. In 4 cases, 
pulmonary oedema and/or atelectasis was seen, twice rated as se-
vere. 
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Fig. 16. Endotoxin shock (5 mgr/kg). 
Combined simultaneous blockade (premedication). 
Systolic blood pressure:!: S.D. 
PRE-ENDOTOXIN 
Time 
POSTENDOTOXJN 
Time 
time 
in min. 
in min. S.B.P. S.D. in min. S.B.P. S.D. 
Start + - 110 167,50 14,30 Endotoxin}+ 0 06,30 16,33 dibenzylinel 
- 100 155,20 16,28 injection s 78,80 24,68 
+ trasicor - 90 143,80 17,53 10 76,50 21,40 
- so 136,00 16,46 15 61,20 13,95 
- 70 126,70 14,65 20 57,50 11,61 
- 60 121,70 12,80 30 62,50 13,51 
- 50 116,60 13,50 40 70,70 15,69 
- 40 112,80 16,24 50 78,90 17,99 
End dibenzyline} = 30 109,80 18,94 60 84,30 16,64 20 104,50 19,85 70 84,30 14,07 + trasicor ~- 10 104,10 17,66 80 80,70 14,11 Endoto~in }+ 0 106130 16,33 90 76,00 16,15 1nJect1on 
100 73,90 17,59 
110 72,30 17,82 
120 69,10 18,86 
130 62,55 11,35 
Tab 1 e 16. Endotoxin shock ( 5 mgr/kg). 
Combined simultaneous blockade (premedication). 
n = 10. S.B.P. in mm Hg. 
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FLOW 
[ml/min] 
280~ 
240 
200 
160 
120 
80 
40 
E 
v 
60 120 time 
Fig. 17. Endotoxin shock (5 mgr/kg). 
Combined simultaneous blockade (premedication). 
Blood flow~ S.D. 
PRE-ENDOTOXIN 
Time 
in mih. 
Start dibenzyli 
+ trasicor 
ne-4- 110 
> 
End dibenzyline 
+ trasicor f 
Endotoxin f' 
injection 
-
-
-
-
-
-
-
-
-
-
100 
90 
80 
70 
60 
50 
40 
30 
20 
10 
0 
Blood 
flow 
98,10 
99,30 
94,33 
91,34 
88,84 
77,86 
75,20 
74,64 
70,78 
64,94 
63,18 
55,70 
S.D. 
7,32 
7,04 
15,61 
25,42 
23,53 
16,06 
16,07 
19,43 
23,62 
18,57 
11,32 
9,48 
Table 17. Endotoxin shock (5 mgr/kg). 
Endotox 
injecti 
POSTENDOTOXIN 
Time Blood 
in min. flow 
in + 0 55,70 
on 1 5 17,83 
10 28,38 
15 30,48 
20 30,40 
30 25,20 
40 32,38 
50 33,94 
60 34,52 
70 32,30 
80 25,20 
90 27,04 
100 28,68 
110 22,82 
120 24,38 
Combined simultaneous blockade (premedication). 
n " 4. Blood flow in ml/min. 
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in min. 
S.D. 
9,48 
14,40 
24,51 
19,38 
21,53 
19,48 
25,14 
26,45 
31,74 
26,74 
20,38 
17,69 
16,43 
18,54 
19,68 
- E 
PR 
6
,4 [mmh!>min.mt.-1] 
0 
;-5,6 
4,8 
1-4.0 
32 
;-2.4 
I/ ,...... l/ I'-;- r-1'-
"+-r--r v 
'- / 
-"---" 1- . 
1.6 
0,8 
0 I I I I I I 
-120 0 60 120 time 
Fig. 18. Endotoxin shock (5 mgr/kg). 
Combined simultaneous blockade (premedication). 
Peripheral resistance ± S.D. 
PRE-ENDOTOXIN 
Time 
in min. 
Start di benzyl i ne }'- 110 
+ trasicor - 100 
- 90 
End dibenzyline} 
+ tras1cor -r 
Endoto~ in }-> 
lnJeCtlon 
- 80 
- 70 
- 60 
- 50 
- 40 
- 30 
- 20 
- 10 
0 
P.R. 
1 .. 34 
L23 
1,00 
0,91 
0,90 
0,92 
0,82 
0,81 
0,95 
0,81 
0,86 
1, 02 
S.D. 
0,31 
0,32 
0,06 
0,05 
0112 
o., 11 
0,05 
0,12 
0.,25 
0,14 
0,29 
0,48 
Table 18. Endotoxin shock (5 mgr/kg). 
POSTENDOTOXIN 
Time 
in min. 
Endotoxin}+ o 
injection s 
10 
15 
20 
30 
40 
50 
60 
70 
80 
90 
100 
110 
120 
p. R. 
1 ,02 
2,83 
1, 74 
1,10 
1 ,OS 
1,53 
1,20 
1,38 
1,87 
L65 
1,99 
1,65 
L 71 
1,65 
1,62 
Combined simultaneous blockade (premedication). 
n = 4. P.R. in mm Hg /min. /m 1 . 
in min. 
S.D. 
0,48 
2,18 
1,34 
1,07 
0,88 
1 ,31 
1,03 
1,33 
1,30 
1,06 
1,18 
0,98 
0,94 
0,91 
0,82 
79 
Discussion: 
Differences in survival are not statistically significant. It 
seems that batchnumber 581374-2 had a diminished lethality. In 
the part of the series i'n-which this batch was used, the animals 
did survive the impact of the endotoxin when no treatment was 
given, but not anymore after complete adrenergic blockade as pre-
medication. 
This could mean that in the first phase of shock the animal 
"needs" only the alpha-blockade and is worse of when the blockade 
is complete, and that beta-adrenergic functions in the first phase 
still have a beneficial role. 
On comparison of Fig. 10 (monophasic dibenzyline) with Fig. 16,it 
is seen that completing the blockade by addition of beta-blocking 
makes no difference in blood pressure decline. 
Endotoxin leads to a small, temporary additional decrease of the 
systolic pressure in the first phase of shock, when no beta-
blockade is added to the dibenzyline pretreatment (Fig. 10). 
When beta-blockade is added to.the pretreatment [Fig. 16), the 
blood pressure decrease in the first phase is more progressive. 
The blood flow curve [Fig. 17) illustrates that the flow declines 
during simultaneous blockade pre-endotoxin, whereas it rises 
during infusion of solely dibenzyline {Fig. 11). 
Endotoxin subsequently decreases the blood flow even more to a 
level far below that of animals pretreated with solely dibenzyline. 
The blood flow has no tendency to rise later on. The possible ex-
planation is given in Fig. 18: the peripheral resistance, deducted 
from blood pressure and blood flow, appears to be increased after 
endotoxin in this group and is,at nearly all times, during the re-
gistrated shock periods above the P.R. in animals pretreated with 
solely dibenzyline (Fig. 12). 
No further use of a statistical test for differences in the blood 
flow was considered necessary, because in these experiments the 
levels of the mean blood flow after endotoxin were at all times 
lower than these levels after premedication with solely dibenzy-
line (Fig. 11) and in the range of untreated animals (Fig. 8). 
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Conclusions: 
Addition of trasicor to premedication with dibenzyline did not 
improve the shock pattern after endotoxin. 
The first phase of shock is more severe than after pretreatment 
with solely dibenzyline. 
This might indicate that the first phase is a pure alpha-adrener-
gic phenomenon, because shock parameters deteriorate furtherupon 
additional beta-blockade. 
81 
c. 3-7 Combined biphasic blockade 
C. 3-7-1 Combined biphasic blockade 5 mgr/kg endotoxin 
Objective: To investigate the influence of combined biphasic 
adrenergic blockade on survival and haemodynamics in 
endotoxin shock. 
Materials and methods: The endotoxin dose was 5 mgr/kg bodyweight, 
batchnumbers used: 260253, 572818 and 
581374-1. The biphasic blockade consisted of premedication with 
15 mgr/kg bodyweight dibenzyline and medication after endotoxin 
injection with 1,5 mgr/kg bodyweight trasicor. 
Twelve paired experiments (treated versus untreated animals) were 
performed. Some other experiments were non-paired. In total 18 
animals received biphasic blockade and 16 animals were not trea-
ted. Blood pressure, -flow and peripheral resistance are presented' 
in this chapter, as far as the experiments with biphasic blocka-
de are concerned. 
The data of the untreated group were combined with those of other 
untreated series to form a compiled control group (C. 3-4 and 
C. 3-7-3).Systolic blood pressure was measured in all experiments. 
In 9 experiments with biphasic blockade, mean values of systolic 
and diastolic blood pressures were registrated to compare mean 
blood pressure with systolic blood pressure. The trend of the 
systolic blood pressures of the 18 biphasically treated dogs was 
considered in the following intervals: 
0 + 5 min.; 5 + 10 min.; 10 + 30 min.; 30 + 90 min. and 90 + 120 
min. after endotoxin injection. Trends were analyzed with the 
Wilcoxon-test, the test in related samples and the Mann-Whitney-
U test (55,56) with a significance level of alpha=O,C5. 
These trends were also compared with the blood pressure trends in 
the compiled controlgroup of 25 untreated animals, described in 
chapter C. 3-4. 
In 9 experiments with biphasic blockade, reliable blood flow cur-
ves and thus peripheral resistance curves were obtained. By means 
of the Mann-Whitney-U test it was checked at which moments after 
endotoxin injection, the mean flow in these experiments showed a 
significant difference from the mean flow in the 14 experiments 
82 
with endotoxin shock without treatment, described in chapter 
C. 3-4 (alpha=0,05).The test was one sidedly performed against 
the alternative that the flow in untreated dogs is on the average 
smaller than the flow in the treated dogs (55,56). 
Trends in the changes of the mean blood flow were analyzed, apply-
ing the same statistical tests as in the analysis of blood pressure 
trends (alpha= 0,05). 
The heart rates of the biphasically treated and untreated animals 
were compared at T : 0 and T = 120 after endotoxin injection, 
applying the Mann-Whitney-U test (two sidedly performed), with a 
significance of alpha= 0,05). 
Results: 
1. Survival: In the treated group, 15 out of 18 dogs survived 
>14 days. In the untreated group, 4 out of 16 dogs 
survived >14 days: 
Biphasic 
blockade 
Control-
group 
Number 
of 
dogs 
18 
16 
Dibenzyline Endotoxin 
mgr I kg mgr/ kg 
bw bw 
15 5 
- 5 
Trasicor Survival/ 
mgr/kg death 
bw 
15 
1,5 survived 
>14 days 
3 
died 
4 
- survived 
>14 days 
12 
Applying the Binomial test for the statistical analysis of the 
survival data in the paired experiments, the percentage of defi-
nitive survivors appears to be significantly higher in the 
treated group than in the untreated group, with a p-value <0,035. 
Applying the Chi-square-test for the same statistical analysis of 
survival of all treated and untreated animals (paired as well as 
unpaired experiments), the differences in survival are signifi-
cant with a p-value <0,0002. 
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2. Blood pressure: Calculations of average values of mean blood 
pressure and systolic blood pressure are given in Table 19 and 
20. Fig. 19 and 20 are the graphic illustrations of the same. 
The average value of systolic blood pressures in the experi-
mental animals of this group decreases from 176 mm Hg + 
101 mm Hg, during dibenzyline infusion. In the first 5 min. 
after endotoxin injection, a further decrease to 85 mm Hg, 
followed by an increase to 95 mm Hg at 10 min. is seen. 
Both the decreasing and increasing trend proved statistically 
significant. From 10 + 30 min. no significant trend is found. 
The decrease in systolic blood pressure from 98 mm Hg at 30 
min. after endotoxin injection to 73 mm Hg at 120 min. after 
endotoxin injection,a1so represents a significant trend. 
In comparison with the trends in blood pressure of the compi-
led controlgroup in chapter C. 3-4, it can be seen that the 
pressure in the biphasically treated dogs increases already 
significantly after 5 min., whereas in the untreated dogs the 
recovery of the blood pressure starts only at 10 min. after 
endotoxin. 
Comparison of Fig. 19 and 20 shows that the average value of 
mean blood pressure also follows a biphasic pattern. 
3. Blood flow: Table 21 gives the calculations of mean blood flow, 
which are graphically illustrated in Fig. 21. 
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The flow increased from 120 ml/min. + 180 ml/min., during di-
benzyline infusion. Endotoxin injection gave a decrease from 
175 ml/min. + 125 ml/min. at 5 min. after the injection, fol-
lowed by an increase to 134 ml/min., at 10 min. after the in-
jection. A further increase in flow to 151 ml/min. at the start 
of the trasicor infusion was followed by a decrease to 82 ml/ 
min. at 70 min. and a later increase. to 105 ml/min., at 140 
min. after endotoxin injection. 
Trends in mean blood flow: from 0 * 5 min. after endotoxin in-
jection: S.D.T.; 5 + 10 min.: N.S.T.; 10 + 30 min.: N.S.T.; 
30 + 70 min.:S.D.T. and 70 + 130 min.: N.S.T. (Fig.32.,~.111 ). 
The statistical analysis of the differences in blood flow be-
tween these biphasically treated and untreated dogs, described 
in chapter C. 3-4, gave the following results: 
At all moments after the injection of endotoxin, the flow in 
the treated dogs was significantly higher than in the untrea-
ted dogs. 
4. Peripheral resistance: Table 22 gives the values of the peri-
pheral resistance and Fig. 22 is the graphical illustration. 
The P.R. decreases under the influence of dibenzyline: from 
1,27 mm Hg/min.ml +0,25 mm Hg/min./ml. 
Endotoxin injection thereafter gives no increase (0,29 mm Hg/ 
min./ml at 5 min. after endotoxin injection). The P.R. remains 
low during trasicor infusion. 
5. Heart rates: The following average values with S.D. are rele-
vant: At T = 0 : 229 beats/min (S.D. 38); at T = 120 : 130 
beats/min. (S.D. : 28). 
Applying the Mann-Whitney-U-Test, at T = 0 the heart rate in 
the biphasically treated group was found to be significantly 
higher than the heart rate in the untreated group ( 164 beats/ 
min. (S.D. : 29). At T = 120 the heart rate in the treated 
group was significantly lower than the heart rate in the un-
treated group ( 156 beats/min (S.D.: 29). 
6. Autopsy findings: All non-surviving animals in the untreated 
group showed at autopsy a more or less severe degree of the 
characteristic intestinal haemorrhagic necrosis. Three untrea-
ted animals had light pulmonary changes. In the non-surviving, 
biphasically treated animals, pulmonary oedema was the predo-
minant feature at autopsy. None of these animals had haemor-
rhagic lesions in the intestines. 
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Fig. 19. Endotoxin shock (5 mgr/k?)-Biphasic adrenergic blockade. 
Mean blood pressure! S.D. 
Start 
dibenzyline}+ 
End 
dibenzyline}+ 
Endotoxin r' 
injection 
PRE ENDOTOXIN -
Time 
in min. M. B. P. 
- 120 153,66 
- 110 145,44 
- 100 129 1 11 
- 90 113,88 
-
80 105,88 
- 70 97,55 
- 60 89,88 
- 50 85tll 
- 40 72,88 
- 30 68,66 
- 20 67,00 
- 10 63,771 
0 58,66 
S.D. 
23,04 
23,67 
27,03 
25,34 
23,87 
18,81 
16,22 
12,46 
8,23 
7,36 
11 ,67 
5,47 
7,00 
POSTENDOTOXIN 
Time 
in min. M.B.P. S.D. 
Endotoxin}+O 58,66 7,00 
injection s 50,88 16,82 
10 60,77 20,27 
Start 20 63,44 17,70 trasicor}-r!~ 62,66 10,02 
75,11 12,83 
50 67,77 16,96 
60 65,00 17,38 
70 62,66 18,94 
80 59,77 18,29 
90 57,88 17,94 
100 56,00 17,57 
End II 0 54,33 17,05 
trasicor--r120 53,88 16,24 
Table. 19. Endotoxin shock (5 mgr/kg) .Biphasic adrenergic blockade. 
n = 9. M.B.P. in mm Hg. 
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Fig. 20. Endotoxin shock (5 mgr/kg). Biphasic adrenergic blockade. 
Systolic blood pressure:± S.D. 
PRE-ENDOTOXIN j'_OSTENDOTOX IN 
Time Time 
in min. S.B.P. S.D. in min. S.B.P. S.D. 
Start + - 110 176,13 25,50 Endotoxin}+ o 01,16 17,81 
d i benzyl in~ 
- 100 169,S6 30,51 injection s 85,48 22,68 
-
90 156,36 35,39 10 95,48 23,88 
- so 141,28 29,27 1S 94,52 20,80 
- 70 130,20 24,62 Start 20 96,04 21,81 
- 60 121,48 20,25 trasicor}+ ~~ 98,88 20,45 
- so 11S,68 19,90 94,76 21,76 
- 40 109,24 19,66 so 89,44 21 113 
- 30 104,32 18,7S 60 86,16 18,24 
End dibenzyline - 20 103' 32 17,64 70 82,00 17,32 + 101,40 16,63 80 79,S6 18,66 - 10 
Endotoxin injection + 0 101,16 17,81 90 76,92 18,S8 
100 76,28 19,11 
110 74,80 19,10 
End . }+120 73,92 19171 tras1cor 130 74,32 18,88 
Table 20.Endotoxin shock (5 mgr/kg).Biphasic adrenergic blockade. 
n = 18. S.B.P. in mm Hg. 
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Fig. 21. Endotoxin shock (5 mgr/kg).Biphasic adrenergic blockade. 
Blood flow:': S.D. 
Start + 
dibenzyline} 
End 
dibenzyl ine }+ 
Endotoxin t· 
injection 
PRE-ENDOTOXIN 
Time Blood 
in min. flow 
- 120 113,00 
- 110 120,33 
- 100 126,44 
- 90 125,33 
-
80 130,11 
- 70 148,11 
- 60 158,44 
-
50 167,44 
- 40 169,44 
- 30 180,22 
- 20 181 ,33 
- 10 180,44 
0 175,00 
S.D. 
29,94 
28,52 
32,72 
35,19 
44,36 
56,15 
65,20 
65,53 
71,46 
73,11 
73,74 
77,96 
79,54 
Endotox1 
injectio 
Start 
trasicor 
End 
trasico r 
POSTENDOTOXIN 
Time Blood 
in min. flow S.D 
n -> 0 175,00 79,54 
n} 5 125,55 22,99 
10 134,66 25,88 
20 148,88 23,95 
}+ 30 151,44 23,02 
40 122,66 15,43 
50 103,33 12,59 
60 96,77 10,58 
70 82,44 8,46 
80 86,00 4,95 
90 85,33 5,46 
100 87,77 9,35 
110 98,55 8,88 
}-> 120 98,00 11 ,07 
130 99,66 11,03 
140 105,00 10,63 
Table 2l.Endotoxin shock (5 mgr/kg).Biphasicadrener-gic blockade. 
n = 9. Blood flow in ml/min. 
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P.R[mmHg/min/ml-1] 
6,4 
5.6 
4,8 
4,0 
3.2 
2.4 
E. 
0 
Fig. 22. Endotoxin shock (5 mgr/kg).Biphasic adrenergic blockade. 
Peripheral resistance ± S.D. 
PRE-ENDOTOXIN POSTENDOTOXIN 
Time Time 
in min. P.R. S.D. in min. P.R. S.D. 
Start - 120 1,27 0,29 Endotoxin f' 0 0,25 0,11 
dibenzyline}+ - 110 1,09 0,24 injection 5 0,29 0,22 
- 100 0,95 0,26 10 0,37 0,27 
- 90 0,78 0,24 Start 20 0,35 0,20 
-
80 0,69 0,28 trasicor}->- 30 0,33 0,15 
- 70 0162 0,26 40 0,49 0,16 
- 60 0,53 0,27 50 0,51 0,21 
-
50 0,46 0,24 60 0,49 0,23 
- 40 0,37 0,17 70 0,55 0,26 
End - 30 0,31 a, 11 80 0,44 0,18 
di benzyl in e}·> - 20 0,29 0,10 90 0,43 0,19 
Endotoxin - 10 0,27 0,10 100 0,40 0,20 
injection f' 0 0,25 0,11 End 110 0,36 0,20 
trasicor}+ 120 0,35 0,18 
130 0,34 0,18 
140 0,34 0,17 
Table. 22. Endotoxin shock ( 5 mgr/kg) .Biphasic adrenergic blockade. 
n 
" 
9. p. R. in mm Hg/min./ml. 
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Discussion: 
As stated in chapter C. 3-4 on endotoxin shock without treatment, 
5 mgr/kg Endotoxin coli (0127:68 Difco Laboratories, Detroit) 
proved not to be a L.D. 95%. 
The question if biphasic adrenergic blockade improved survival in 
canine endotoxin shock,could therefore not be answered by compa-
rison of the survival percentage after such a treatment with the 
5 percent of animals, which supposedly could survive without such 
a treatment. It was therefore necessary to set up our own untrea-
ted control experiments. 
Thus, statistical comparison of the percentage of survivors in 
the biphasically treated and untreated experiments showed that 
biphasic adrenergic blockade significantly improved survival. 
Dibenzyline premedi-cation led to a significantly earlier recovery 
of blood pressure after endotoxin injection, as compared with 
experiments without this premedication. 
Although the blood flow after endotoxin injection in the treated 
animals also followed a biphasic pattern,it was at all times higher 
than in untreated animals and increased again in the second phase 
of shock. 
One of the main reasons for the beneficial influence of dibenzy-
line is probably that, after dibenzyline premedication, endotoxin 
has virtually no influence on the peripheral resistance, which 
remains low throughout the period of measurement. 
During dibenzyline infusion, the heart rate increases significant-
ly. After addition of trasicor, the rate decreases again signi-
ficantly. 
Without addition of trasicor, as in the experiments with monopha-
sic dibenzyline (C.3-5-l), the heart rate remains. high. 
With or without additional trasicor medication,the blood flow af-
ter dibenzyline premedication is significantly higher than in un-
treated cases. Therefore, the addition of trasicor leads to the 
maintenance of a high blood flow with a much lower heart rate and 
thus more effective heart action. 
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Conclusions: 
Biphasic adrenergic blockade effectively improved survival. 
With biphasic blockade, blood pressure recovered earlier in the 
first phase of shock. 
Biphasic blockade resulted in a significantly higher blood flow 
at all moments after endotoxin injection. 
This higher blood flow, apparently caused by the alpha-blockade, 
could be maintained with a much lower heart rate with additional 
beta-blockade. 
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c. 3-7-2 Combined biphasic blockade 6 and 7 mgr/kg endotoxin 
Objective: To increase the endotoxin dose in an effort to work 
out a L.D. 95% endotoxin shock model. This objective 
resulted from foregoing experiments in which 5 mgr/kg endotoxin 
proved not to be a L.D. 95%, but in all control animals to-
gether a L.D. 60% (C. 3-8). 
Materials and methods: Eight paired experiments were done with 
6 mgr/kg bodyweight endotoxin, batchnumber 
used: 568487. Five paired experiments were done with 7 mgr/kg 
bodyweight endotoxin, batchnumber used: 573093-1. 
In the treated animals, 15 mgr/kg bodyweight dibenzyline was given 
as premedication and 1,5 mgr/kg bodyweight trasicor postendotoxin 
as medication. The data on survival ,blood pressure, -flow,periphe-
ral resistance· and heart rates of the experiments with 6 and 7 mgr/kg 
endotoxin were calculated together. 
In all experiments systolic blood pressure was measured. Flow 
measurements were obtained in 5 experiments with biphasic 
blockade and 6 mgr/kg endotoxin and in 3 experiments with bipha-
sic blockade and 7 mgr/kg endotoxin. 
Average values of these data in the 6 and 7 mgr/kg groups were 
calculated separately as well as together. 
It was checked whether the flow of 14 untreated dogs, injected 
with 5 mgr/kg endotoxin (C.3-4), showed a significant difference 
from the flow of 8 biphasically treated dogs, which were injected 
with 6 and 7 mgr/kg endotoxin. 
The Mann-Whitney-U test was used to compare the blood flow in the 
two groups at the moments T= 0, 5, 10, 15 min. etc., after endo-
toxin injection .Survival differences were analyzed with the Binomial 
test. 
Results: 
l. Survival: In the 6 mgr/kg endotoxin experiments, 5 out of 8 
dogs , treated with biphasic blockade and 2 out of 8 dogs 
without treatment survived >14 days. 
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In the 7 mgr/kg endotoxin experiments, 3 out of 5 dogs, treated 
with biphasic blockade survived >14 days, but still 1 out of 5 
dogs without treatment survived after this higher dose of 
endotoxin: 
Number Dibenzyline Endotoxin Trasicor Survival 
of mgrjkg mgr/kg mgr/kg >14 days 
Biphasic 
blockade 
Control-
group 
Biphasic 
blockade 
Control-
group 
dogs 
8 
8 
5 
5 
bw 
15 
-
15 
-
bw bw 
6 1,5 5 
6 - 2 
7 1, 5 3 
7 - 1 
The amount of definitive survivors in the treated groups taken 
together (8 out of 13), is significantly higher in comparison 
with the untreated group (3 out Of 13), with a p-value•0,031. 
2. Blood pressure: Table 23 gives the average values of the systo-
lic bloodpressures with S.D. in the untreated group and Table 
24 for the same parameter in the group treated with biphasic 
blockade (both 13 experiments). Fig. 23 and 24 are the graphic 
illustrations of these average values. 
In the untreated group the S.B.P. drops from 184 mm Hg + 
79 mm Hg, after endotoxin injection. Here also the shock 
pattern was biphasic with an increase of the S.B.P. to 104 
mm Hg,at 60 min, and a subsequent decrease to 76 mm Hg, at 
140 min. 
In the treated group the S.B.P. decreases from 98 mm Hg+ 
75 mm Hg at 5 min. after endotoxin injection and increases 
again to 83 mm Hg at 10 min. after endotoxin injection. 
The S.B.P. curve is comparable with the pattern after injection 
of 5 mgr/kg endotoxin (Fig.20). 
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3. Blood flow: The average values of the treated groups with S.D. 
are given in Table 25,26 and 27. Fig. 25,26 and 27 are the 
graphic illustrations of the same. 
In the experiments with 6 mgr/kg endotoxin, the flow recovered 
between 5 and 10 min. after endotoxin injection. In the ex-
periments with 7 mgr/kg endotoxin, it did not (anymore). The 
average values of both groups together do show a recovery in 
this phase. 
The flow decreased in both groups after 30 min. and in the 
group with 7 mgr/kg endotoxin, it did already before trasicor. 
In the group with 6 mgr/kg endotoxin (and in the summation 
of the experiments with 6 and 7 mgr/kg endotoxin), the blood 
flow subsequently has a tendency to rise during and after the 
trasicor phase. In the experiments with 7 mgr/kg endotoxin, 
it has not. The flow in the treated animals is comparable with 
the pattern after 5 mgr/kg endotoxin (Table 21 and Fig. 21), 
but the average level is lower. For example, 5 mi'n. after en-
dotoxin injection, the mean flow with S.D. in the 6 mgr/kg 
group is below the values in the 5 mgr/kg group: the 6 mgr/kg 
flow is 56,38 ml/min. with S.D. 29,75 ml/min., the 5 mgr/kg 
flow is 125,55 ml/min. with S.D. of 22,90 ml/min. 
At 130 min. after endotoxin injection, the values are 57,38 
ml/min. with S.D. 11,88 ml/min. and 99,66 with S.D. 11,03 ml/ 
min. respectively. 
On statistical comparison of the flow in the treated dogs with 
the controlgroup (C. 3-4), it was found that at the moments 
T = 0, 40, 50, 60, 70, 80, 90 and 100, the difference in flow 
was not significant. 
At the moments T = 5, 10, 15, 20 and 30 and also at themoments 
T = 110, 120 and 130, the flow was significantly higher in the 
treated dogs. 
4. Peripheral resistance: The average values of the peripheral 
resistances of the 6 and 7 mgr/kg endotoxin group with bipha-
sic blockade were not essentially different from the P.R.'s 
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in the 5 mgr/kg endotoxin experiments with biphasic blockade 
and were for that reason calculated together with the 5 mgr/kg 
endotoxin group (Table 22 and Fig. 22). Results are given in 
chapter C. 3-7-3. 
In short, the P.R. in the 6 and 7 mgr/kg endotoxin experiments 
with biphasic blockade decreased from a level> 1,0 mm Hg/min./ 
ml + <0,5 mm Hg/min./ml and after endotoxin injection never 
surpassed a level of 0,75 mm Hg/min./ml. 
5. Heart rates: The following average values with S.D. are rele-
vant: In the treated group at T = 0 : 220 beats/min (S.D.: 36); 
at T = 120: 118 beats/min. (S.D. : 22 ). 
In the untreated group at T = 0 : 157 beatsjmin. (S.D: 16); 
at T = 120:140 beats/min. (S.D. : 33). 
The heart rate at T = 0 in the treated group was found to be 
significantly higher than in the untreated group. 
The difference was not significant at T = 120. Differences in 
heart rate between these experiments with biphasic blockade 
after 6 • 7 mgr/kg endotoxin and those after 5 mgr/kg endo-
toxin were not significant at T = 0, nor at T = 120 (C3-7-1). 
6. Autopsy findings: In the 6 mgr/kg experiments the autopsy fin-
dings in the 3 non-surviving treated animals were as follows: 
one had a light pulmonary oedema, one a severe pulmonary oe-
dema with both showing very light intestinal changes. In the 
third autopsy there were no pulmonary changes, but 1 ight in-
testinal lesions were found. 
Five out of the 6 non-surviving untreated animals had intesti-
nal damage, rating from well recognizable to severe haemorrha-
gic necrosis. In the sixth case, the cause of death was an in-
vagination. 
Pulmonary changes occurred once. In the 7 mgr/kg experiments, 
three out of the 4 non-surviving non-treated animals showed a 
severe intestinal haemorrhagic necrosis, in the fourth case the 
haemorrhagic changes were rated light. 
No pulmonary changes occurred. The 2 non-surviving treated 
animals presented a distinct pulmonary oedema and no gastroin-
testinal changes. 
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Fig. 23. Endotoxin shock (6->7 mgr/kg). No adrener 0ic blockade 
Systolic blood pressure~ S.D. 
PRE-ENDOTOXIN POSTENDOTOXIN 
Tim·e Time 
in min. S. B. P. S.D. in min. S.B.P. S.D. 
Endotoxin 
injection }+ 
- 120 
- 110 
- 100 
-
90 
- 80 
- 70 
- 60 
- 50 
- 40 
- 30 
- 20 
- 10 
0 
187,00 
186,30 
185,90 
186,20 
186,60 
187,20 
187,10 
186,00 
185, so 
184,90 
184,00 
184,30 
184,00 
19,09 
20,01 
Endotoxin f' 0 injection 5 
18,58 10 
18,12 20 
17,51 30 
16,91 40 
16,76 50 
16,65 60 
16,40 70 
16,33 80 
15,93 90 
15,77 100 
15,86 110 
120 
130 
140 
Fig. 23. Endotoxin shock (6+7 mgr/kg).No adrenergic 
n = 13 S.B.P. in mm Hg. 
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184,00 15,86 
79,10 21,08 
70,20 25,35 
73,70 27,80 
86,20 31,53 
97,00 37,41 
101,20 39,82 
104,40 40,23 
97,40 37,43 
93,00 33,92 
87,20 32,79 
81,60 29,12 
80,50 28,29 
78,50 26,00 
77,40 24,78 
76,60 25,13 
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Fig. 24. Endotoxin shock (6+7 mgr/kg). Biphasic ad'renergic blockade. 
Systolic blood pressure~ S.D. 
PRE-ENDOTOXIN POSTENDOTOX IN 
Time Time 
in min. S.B.P. S.D. in min. S.B.P. S.D. 
Start 
- 120 186,45 18,40 Endotoxin f' 0 98,63 12,21 dibenzyline }+ 
- 110 178,36 21,38 injection 5 75,36 20,63 
- 100 157,90 17,76 10 83,09 16,99 
- 90 142181 13,21 Start 20 78,90 16,81 
- 80 134,81 14,66 trasicor }+ 30 80,36 15,43 
-
70 128,63 14,27 40 84,54 19,75 
- 60 122,36 15,42 50 78,63 15,66 
- 50 119,09 17,14 60 73,81 15,04 
- 40 111 '54 19,08 70 71 ,63 15,96 
- 30 107,27 18,54 80 70,18 17,61 
End 
- 20 101 '36 13,74 90 67,27 17,95 dibenzyline }+ 
- 10 100,00 12,41 100 67,36 17,08 
Endotoxin f' 0 98,63 12,21 End 110 64,90 16,84 injection 
trasicor }+120 64,36 16,74 130 64,27 15,70 
140 63,27 14,96 
Table 24.Endotoxin shock (6+7 mgr/kg).Biphasic adrenergic blockade. 
n 
" 
13. S.B.P. in mm Hg. 
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Fig. 25.Endotoxin shock (6 mgr/kg).Biphasic adrenerqic blockade. 
Blood flow t S.D. 
PRE-ENDOTOXIN POSTENDOTOXIN 
Time Blood Time Blood 
in min. flow S.D. in min. flow S.D. 
Start - 120 102,54 41 ,82 Endotoxin )+ 0 139' 03 84,83 dibenzyl ine l_, 
- 110 108,89 43,51 injection 5 56,38 29,75 
- 100 113,43 42,73 10 68,98 60,83 
- 90 122, OS 54,05 15 79,54 82,60 
- 80 112,00 49,69 Start 20 82,39 84,83 
- 70 114,88 47,19 trasicor )·> 30 83,21 83,90 
- 60 117,33 53,52 40 53,83 39,52 
- so 126,26 66,36 50 49,99 8,67 
- 40 132,64 84,39 60 48,00 12,44 
End - 30 13 3, 41 85,94 70 41 '72 14,95 
dibenzyl ine )+ - 20 138,66 87,32 80 43 ,97 12,42 
Endotoxin - 10 139,84 87,41 90 46,82 10,09 
injection )+ 0 139,03 84,83 100 47,64 13,19 
End 110 51 ,31 13,36 
trasicor }-:-120 49,68 16,37 130 57,38 11,88 
Table 25. Endotoxin shock ( 6 mgr/kg).Biphasic adrenergic blockade. 
n = 5 Blood flow in ml./min. 
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Fig. 26.Endotoxin shock (7 mgr/kg).Biphasic adrenernic blockade. 
Blood flow~ S.D. 
PRE-ENDOTOXIN POSTENDDTOXIN 
Time Blood Time Blood 
in min. flow S.D. in min. flow S.D. 
Start 
- 120 127' 77 32,27 Endotoxin )+ 0 170,85 66,04 dibenzylinel+ 
- 110 140,04 44,28 injection 5 96,96 92,83 
- 100 153,40 47,12 10 102,05 83 ,41 
- 90 155,56 35,09 15 95,25 78,20 
-
80 156,16 35,85 Start 20 101,63 79,57 
- 70 167,01 59,03 trasicor )+ 30 79,05 49,11 
- 60 175,40 60,16 40 74,05 37,64 
- 50 170,32 60,06 50 75,49 37,69 
- 40 170,66 53,68 60 67,69 41,18 
End - 30 170,58 44,56 70 63,37 42,95 
dibenzylinel+ - 20 188,16 68,00 80 74,24 37,72 
- 10 179,50 66,98 90 74,04 43,07 Endotoxin )-> 0 170,85 66,04 100 71 '77 35,94 injection 
110 71,77 35,94 End )+ 120 69,65 23,50 trasicor 130 65,92 17,55 
Table 26.Endotoxin shock (7 mgr/kg) .Biphasic adrenergic blockade. 
n = 3. Blood flow in ml/min. 
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Fig. 27.Endotoxin shock (6+7 mgr/kg).Biphasic adrenergic blockade. 
Blood flow~ S.D. 
PRE-ENDOTOXIN POSTENDOTOXIN 
Time Blood Time Blood 
in min. flow S.D. in min. flow S.D. 
Start - 120 112,01 38,31 Endotoxin f' 0 150,96 75,03 
dibenzyline }+ - 110 120,57 43,61 injection 5 71,52 58,40 
- 100 128,42 45,88 10 B1,38 66,30 
- 90 134,62 48,19 15 85,43 75,57 
- 80 128,56 47,96 Start 20 89,61 77,58 
-
70 143,43 54,74 trasicor }+ 30 81,65 68,67 
- 60 139,11 59,79 40 61 ,41 36,91 
-
50 142,78 63,77 50 59,55 24,96 
- 40 146,90 72,66 60 55,38 26,01 
- 30 147,35 71,82 70 49,84 27,93 
End }+ - 20 157,22 79,52 80 55,32 27,21 dibenzyline 
-
10 154,72 77,90 90 57,04 28,05 
Endotoxin }+ 0 150,96 75,03 100 56,69 24,99 injection End 110 58,98 24,15 
trasicor }·> 120 57,17 20,44 130 60,58 13,72 
Table 27.Endotoxin shock (6+7 mgr/kg) .Biphasic adrenergic blockade. 
n = 8. Bloodflowin ml/min. 
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Discussion: 
In the 6 and 7 mgr/kg endotoxin experiments the significant im-
provement of survival with biphasic adrenergic blockade was con-
fi rme d. 
The increased doses of 6 and 7 mgr/kg endotoxin did still notre-
present a L.O. 95%, but a L.D. 77%. 
The biphasic pattern of blood pressure in endotoxin shock is con-
firmed also in these experiments with a higher dose of endotoxin. 
Biphasically treated dogs with 6 or 7 mgr/kg endotoxin had a sig-
nificantly higher blood flow in comparison with untreated 5mgr/kg 
endotoxin cases, only in the range ofT = 0 ~ T = 30 min. after 
endotoxin injection (first phase of shock) and T = 110 ~ T = 130 
min. (well into the second phase), but not in between. 
With 5 mgr/kg endotoxin ( C. 3-7-1), the flow in the treated ca-
ses was at all moments after endotoxin injection significantly 
higher. 
The heart rates in the treated cases were not essentially diffe-
rent from those in experiments with 5 mgr/kg endotoxin. 
Conclusion: 
It can be concluded that the increased dosages of endotoxin had a 
stronger impact on the blood flow, but they still did not repre-
sent a L. D. 95%. 
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C. 3-7-3 Combined biphasic blockade (compiled data) 
5 • 7 mgr/kg endotoxin 
Objectives: To analyse the compiled data on survival, blood pres-
sure, -flow and heart rates in the experiments with 
all three doses of endotoxin. 
To evaluate the blood gas measurements in these experiments and to 
make a systematic analysis of the autopsy findings. 
Materials and methods: Survival: The blood pressure increases or 
decreases in the T = 5 ~ 10 min. interval 
have been investigated with regard to its prognostic value for sur-
vival. This time interval was chosen, because it had proved to be 
a characteristic range in the shock parameters. 
A similar analysis was not made for the blood flow, because here 
the subgroups of survivors and non-survivors with reliable flow 
curves were not large enough. 
Blood pressure: Trends in pressure changes for the whole group of 
31 experiments with biphasic blockade and 5 • 7 
mgr(kg endotoxin were analyzed and compared with those trends in 
the untreated controlgroup, injected with 5 mgr/kg endotoxin, ap-
plying the Wilcoxon matched-pairs signed rank test, the test 
against trends in related samples and the Mann-Whitney-U-test with 
aloha=0,05.Becausethe turning points and the nature of the trends 
(increasing or decreasing) were similar in the biphasic blockade 
experiments with 5,6 or 7 mgr/kg endotoxin, a dose differentia-
tion was not necessary in studying these trends. 
Blood flow and peripheral resistance: In 17 experiments of the 
whole group of biphasic 
blockade with 5 • 7 mgr/kg endotoxin, the blood flow and P.R. we-
re calculated together and compared with those parameters in the 
untreated control group, injected with 5 mgr/kg endotoxin (C. 3-4). 
Peripheral resistances were also calculated in these experiments. 
The trends of the flow changes were investigated for the same 
groups of experiments in the range of 0 • 130 min. after endotoxin 
injection (Wilcoxon-test, test against trends in related samples 
and Mann-Whitney-U-test). The tests were two sidedly performed 
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with alpha= 0,05. Here also, because of the similarity of the tur-
ning points and the nature of the blood flow trends after the 
three different doses of endotoxin, a dose differentiation could 
be omitted in studying these trends. 
Heart rates: The trend of the heart rates was analyzed with the test 
against trend in related samples,two sidedly performed 
at a significance level of alpha= 0,05.As with the blood pressure and 
-flow trends, it was not necessary tc distinguish the differences in 
endotoxin dosages here. 
Blood gas analysis: Differences between treated and untreated dogs 
and survivors and non-survivors in pH- and HCO 3 
values at T = 130 after endotoxin at the end of the experiment, were 
analyzed with the Mann-Whitney-U test (two sidedly performed) with 
alpha= 0,05 (standard normal distribution test statistic is Z.).Be-
cause no significant difference was found for various doses endotoxin, 
a dosage differentiation could be omitted. 
Autopsy findings: Macroscopic and microscopic autopsy findings of 
all non-surviving animals were rated, according to 
the criteria given in chapter C. 3-2 and subjected to a statistical 
test, based on an equidistant score attribution from 0 + 4, in 
which 0 = normal (Yates Cochran test, two sidedly performed, 
alpha = 0,05). The data made it acceptable not to differentiate 
in endotoxin dosage. 
Results: 
!. Survival· 
Number 
Biphasic 
blockade 
Control-
group 
of 
dogs 
31 
29 
Di benzyl i ne Endotoxin 
mgr/ kg mgr/ kg 
bw bw 
15 5 ·> 7 
- 5 -> 7 
Trasicor Survival/ 
mgr/kg death 
bw 
23 
1,5 survived 
>14 days 
8 
died 
7 
survived 
- >14 days 
22 
died 
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The percentage of surviving treated animals in the combined 
group is significantly higher than the percentage of untreated 
survivors with a p-value <0,001 (Binomial test). 
Survival prediction: At alpha = 0,05, no significant differen-
ces in blood pressure increase or decrease 
were found in the T = 5 -> 10 min. interval between the survi-
vors and non-survivors, both in the treated and untreated group. 
2. Blood pressure: The average values of the systolic blood pres-
sure in this combined group with biphasic blockade decreased 
from 99 mm Hg at 0 min. + 80 mm Hg at 5 min after endotoxin in-
jection. It increased to 89 mm Hg at 10 min., remained at this 
level up till 30 min. after endotoxin injection and decreased 
again to 68 mm Hg at 120 min. after endotoxin injection. 
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Trends of the blood pressure changes: from 0 + 5 min. after 
endotoxin injection: S.D.T.; 5 + 10 min.: S.I.T.; 10 + 30 min.: 
N.S.T., and 30 + 120 min. after endotoxin injection: S.D.T. 
Fig. 28 gives the graphic illustration and comparison with 
the untreated group, described in chapter C. 3-4. 
S.B.P. 
(mm Hg) 
0 
0 10 
t 
End. 
30 
• Biphas.Block.,5-7 mgr,n=31 
o Untreated, 5 mgr, n=25 
50 70 90 110 130 Time in min. 
Fig. 28. Trends of S.S.P. in untreated exp.(5 mgr/kg endo-
toxin) and biphasic blockade exp. (5 + 7 mgr/kg 
endotoxin). 
3. Blood flow: Table 28 gives the calculations of the mean blood 
flow in this combined group of animals treated with biphasic 
blockades. Fig. 29 (p. 109) is the graphic illustration. 
Fig. 30 (p. 110) represents the mean blood flow with S.D. of 
the biphasic blockade group of 5 + 7 mgr/kg and the untreated 
5 mgr/kg group together (C. 3-4), in order to visualize the 
difference of this parameter in endotoxin shock with biphasic 
treatment and endotoxin shock without treatment. 
Finally, Fig. 31 (p. 110) gives the graphic illustration of the 
compiled data on mean blood flow after endotoxin in various groups 
studied (C. 3-4 up till C. 3-7-3),to be able to compare the 
effects of various dosages and treatments on mean blood flow. 
The statistical comparisons of these data are described in the 
various chapters. 
Trends of the blood flow changes: from 0 + 5 min. after endo-
toxin: S.D.T.; 5 -> 10 min.: S.I.T.; 10 + 30 min.: N.S.T.; 
30 + 70 min.: S.D.T. and 70 + 130 min. after endotoxin injec-
tion: S.!.T. These results are illustrated in Fig. 32 (p.111 ). 
Statistical comparison of these data with the untreated control-
group led to the following conclusions: 
1. After endotoxin injection the flow drops immediately in the 
treated as well as in the untreated dogs. 
In all cases the flow decrease in the 0 + 5 min. period is 
larger in the untreated dogs. 
2. In most cases the recovery ( " flow increase) in the bipha-
sically treated dogs already sets in after 5 min. 
In untreated dogs a recovery only takes place in the period 
of 10 +50 min. 
3. The recovery of blood flow in the 5 + 10 min. period after 
endotoxin is significantly greater in the group of treated 
dogs than the flow increase during this interval in the 
group of untreated dogs. 
4. In the 70 + 130 min. period after endotoxin, blood flow in 
untreated 5 mgr/kg experiments had a significantly decreas-
ing trend. In the same period biphasically treated animals 
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with 5 + 7 mgr/kg endotoxin had a significantly increasing 
trend in blood flow. 
4. Peripheral resistance: The calculations of the peripheral re-
sistances in this combined group are given in Table 29. 
Fig. 34 (p. 112) is the graphic illustration of these data. 
Fig. 33 (p. 111) represents the P.R. of the biphasic blockade 
group (5 + 7 mgr/kg) and the untreated 5 mgr/kg (C. 3-4) to-
gether, in order to visualize the difference of this parameter 
in endotoxin shock with biphasic treatment and without treat-
ment. 
5. Heart rates: With biphasic blockade, in the range of T = -120 + 
T = 0 min. ,a significantly increasing trend in heart rate was 
found; in the range of T = 0 + T = 120 min. the trend was sig-
nificantly decreasing.In untreated experiments the trend from 
T = 0 + T = 120 was significantly increasing. 
6. Blood gas analysis (Astrup method): In blood samples of 29 
animals without treatment and of 31 animals with biphasic 
adrenergic blockade,pH- and HC0 3 values were measured at 
various moments during the experiments. 
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The data concern 22 non-survivors and 7 survivors in the un-
treated group and 8 non-survivors and 23 survivors in the 
treated group: 
a. Untreated dogs, 5 + 7 mgr/kg endotoxin. 
Both pH- and HC0 3 values in the group of 22 non-survivors 
are significantly lower than in the group of 7 survivors 
(pH: Z =- 3,43; HC0 3-: Z = - 3,31). 
b. Biphasically treated dogs, 5 + 7 mgr/kg endotoxin. 
The pH-value in the group of 8 non-survivors is signifi-
cantly lower than in the group of 23 survivors. 
For the variable HC0 3-, no significant difference was found 
here 
(pH: Z =- 2,47; HC0 3-: Z =- 0,64). 
In view of these results, survivors and non-survivors have 
been separated in the following groups: 
a. Non-surviving dogs, 5 + 7 mgr/kg endotoxin. 
No significant difference was found for both pH- and HC0 3 
values between the group of 22 untreated dogs and the group 
of 8 biphasically treated dogs. 
(pH: Z =- 1,02; HC0 3-: Z = 1,38). 
b. Surviving dogs, 5 + 7 mgr/kg endotoxin. 
No significant difference was found here either for both 
pH- and HC0 3 values between the groups of 7 untreated dogs 
and 23 biphasically treated dogs. 
(pH: Z =- 0,13; HC0 3- : Z - 0,73). 
7. Autopsy findings: Macroscopic and microscopic findings were 
rated according to the criteria, described in chapter C. 3-2. 
Macroscopically,the characteristic haemorrhagic necrosis of 
the bowel mucosa was severe in untreated dogs and mostly ab-
sent in biphasically treated dogs. 
Intestines and mesenterial bloodvessels usually were contrac-
ted and pale in untreated cases. 
The mucosal haemorrhagic necrosis was mostly severe in duode-
num and small intestines and less severe in large bowel and 
rectum. 
Pulmonary oedema was found in a number of treated dogs. 
Microscopically, it proved impossible to differentiate the le-
sions of the intestinal mucosa in shock effects and autolysis. 
Statistical analysis: 
a. M a c r o s c o p i c findings: 
The amount of untreated animals in which the lesions of the 
intestinal mucosa were rated as severe, was significantly 
higher than in the biphasically treated animals, the amount 
of biphasically treated animals in which the degree of pul-
monary oedema was rated as sever,e, was significantly higher 
than in the untreated animals. 
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b. M i c r o s c o p i c findings: 
The difference in microscopic changes in lungs, small bowel, 
colon and kidneys between treated and untreated dogs were 
not statistically significant. 
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Fig. 29.Endotoxin shock (5+7 mgr/kg).Biphasic adrenergic blockade. 
Blood flow~ S.D. 
Start -> 
dibenzyl ine} 
End 
dibenzyline}+ 
Endotoxin 
injection }+ 
PRE-ENDOTOXIN 
Time Blood 
in min~ f) ow· 
- 110 117,22 
- 100 124,88 
- 90 130,69 
- 80 129,91 
- 70 146,71 
- 60 155,07 
- 50 159,04 
- 40 165,04 
- 30 172,52 
- 20 179,00 
- 10 181,10 
0 177,85 
S.D. 
3Q 118 
34,31 
40,87 
45,02 
51,92 
61,63 
66,21 
70,84 
71,97 
72,69 
74,00 
72,94 
POSTENDOTOXIN 
Time Blood 
in min. f·low 
Endotoxin }+ 0 117,85 
i nj ecti on 5 105,81 
10 116,37 
15 122,18 
Start 20 130,68 
trasicor }+ 30 130,94 40 98,67 
50 84,76 
60 79,85 
70 69,09 
80 69,24 
90 73,78 
100 76,45 
End 110 77,95 
trasicor }+ 120 81,86 130 81 1 7Q 
140 87,00 
!50 89,40 
S.D. 
72,94 
70,63 
75,83 
79,39 
78,94 
79,14 
52,72 
40,57 
37,45 
30,95 
28,52 
26,40 
33,06 
28,59 
35,63 
35,96 
33,05 
34,72 
Table. 28.Endotoxin shock (5+7 mgr/kg).Biphasic adrenergic blockade. 
n = 17. Blood flow in ml/min. 109 
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Fig. 30. Mean blood flow differences between biphasic blockade exp. 5 + 7 
mgr/kg endotoxin) and untreated exp. (5 mgr/kg endotoxin). 
Flow 
( ml./min.) 
200 
0 
0 10 
t 
End. 
110 
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• Biphas. Block., 5 mgr., n=9 
• Biphas.Block., 6-7 mgr., n=8 
.a. Monoph.Dibenz., 5mgr, n=5 
., Monoph. Tras., 5 mgr, n=4 
o Untreated, 5 mgr., n=14 
50 70 90 110 130 Time in min. 
Fig. 31. Compiled data on mean blood flow after endotoxin 
in various experimental groups. 
• Biphas. Block, 5 mgr, n=9 
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t Fig. 32. Trends of blood flow in untreated exp ( 5 mgr/kg 
End. 
endotoxin) and biphasic blockade exp. ( 5 and 
5 -> 7 mgr/kg endotoxin). 
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Peripheral resistance + S.D. 
PRE-ENDOTOXIN POSTENDOTOXIN 
Time Time 
in min. P.R. S.D. in min. P.R. S.D. 
Start f' - 110 1.15 0,28 Endotoxin dibenzyl ine 
- 100 1,02 0,32 injection f' 
0 0,29 0,16 
5 0,42 0,30 
- 90 0,86 0,27 10 0,52 0,41 
- 80 0,74 0,28 Start 
-
70 0,65 0,24 trasicor 
- 60 0,56 0,26 
20 0,46 0,37 
}+ 30 0,39 0,24 
40 0,42 0,26 
- so 0,51 0,28 50 0 .. 69 0,47 
- 40 0,43 0,26 60 0,65 0,36 
End - 30 0,37 0,24 
dibenzyline }+ - 20 0,33 0,18 
Endotoxin - 10 0,33 0,17 
injection }+ 0 0,29 0,16 
End 
trasicor 
70 0,65 0,38 
80 0,62 0,33 
90 0,55 0,26 
100 0,48 0,21 
110 0,47 0,25 
}+ 120 0,45 0,25 
130 0,46 0, 31 
140 0,43 0,27 
150 0,42 0,24 
Table 29.Endotoxin shock (5+7 mgr/kg).Biphasic adrenergic blockade. 
n = 17. P.R. in mm Hg/min./ml. 
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Discussion: 
In the experiments with biphasic blockade, the turning points and 
the nature of the blood pressure and flow trends (increasing or 
decreasing) are similar with those of the experiments with injec-
tion of different endotoxin dosages. 
It seemed therefore reasonable not to distinguish between the 
different dosages of endotoxin in studying these trends. 
Fig. 30 (p. 110) suggests that the trend of the blood flow in the 
second phase is upwards in the treated cases and downwards in the 
untreated cases for this compiled group. 
These trends are confirmed in the statistical analysis (Fig. 32, 
p. 111). The values of blood flow and peripheral resistance are 
inversely related. 
Changes of heart rates in the combined group gave no new informa-
tion. The values of pH and HC0 3 at 120 min. after endotoxin did 
not correlate with the treatment but with survival: pH-values 
were low in non-surviving animals whether or not the animals had 
received an adrenergic blockade and significantly higher in sur-
viving animals, also in treated and untreated cases alike. 
A dose differentiation could be omitted in this analysis also, 
because no significant difference was found for various doses of 
endotoxin. The same applies for the statistical analysis of the 
autopsy findings; the data made it acceptable not to differentia-
te in endotoxin dosages. 
Conclusions: 
The compiled data on survival, blood pressure, -flow and periphe-
ral resistance led to the same conclusions as in the preceding 
chapters. 
The survival increase with biphasic blockade in this combined 
group was significant with a p-value <0,001. The severity of aci-
dosis in late shock proved significantly linked with survival 
prognosis. 
Blood pressure changes shortly after endotoxin did not correlate 
with survival prognosis.Biphasic blockade prevented mostly the 
haemorrhagic intestinal lesions, characteristic for endotoxin shock. 
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C. 3-8 Potency of endotoxin 
Objective: To analyse the survival times of untreated animals 
which received endotoxin in a dose of 5 + 7 mgr/kg 
bodyweight in relation to the batches of endotoxin used. 
Introduction: In the main study in which Beagles were used as 
experimental animal, a number of untreated control 
animals survived the endotoxin shock >14 days. 
In the pilot study, in which mongrel dogs were used, none of the 
experimental animals survived the shock procedure. 
This difference could have been due to the different dog model 
used in the main study, to differences in potency of the several 
endotoxin batches used, or to a decline of potency during storage 
time of the different batches. 
Interpretation of the eventual efficacy of therapy in treated 
animals was therefore hampered. 
It was thus necessary to investigate the lethality of the various 
batches and dosages of endotoxin used. 
Materials and methods: In total 9 batches were used. The survival 
data of 48 Beagles,which reveived no anti-
adrenergic treatment, were compared. 
Results: 
In Table 30 the survival data are given for the animals receiving 
5, 6 and 7 mgr/kg endotoxin. 
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Batchnumbers: 
260253 
58137 4-1 
581374-2 
582495-1 
582495-2 
573093-2 
572818 
568487 
581374-2 
573093-1 
581374-2 
5 
Total 
4 
6 
6 
5 
1 
5 
8 
6 
7 
1 
7 
4 
1 
Mgr/kg bodyweight endotoxin 
Number of dogs 
Surviving Non-surviving 
2 2 
0 6 
6 0 
2 3 
0 1 
2 3 
2 6 
Mgr/kg bodyweight endotoxin 
2 5 
0 1 
Mgr I kg bodywei ght endotoxin 
1 3 
0 1 
Table 30. Survival data in the groups with different dosages 
endotoxin. 
Differences of potency of different batches are clear. In only 
one case, batchnumber 5813742, 6 out of 6 dogs survived 5 mgr/kg 
bodyweight endotoxin injection. 
When other batches were used, only a few animals survived the en-
dotoxin shock procedure. 
On summation, 5 mgr/kg endotoxin appears to be a L.D. 60% and the 
5,6 and 7 mgr/kg endotoxin doses together represented a L.D. 64%. 
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Discussion: 
Information in literature (18,106) indicated 5 mgr/kg Endotoxin 
coli, codenumber 0127:68, Difco Laboratories, Detroit, as a 
L.D. 95%. These data were not confirmed in our studies. 
The non-lethal outcome of these control experiments could be ex-
plained by a resistance in the experimental animal, by an unin-
tended change in the methodology or by a diminished lethality of 
the endotoxin batch used. 
Most likely, the batches of endotoxin were variable in lethality. 
As a logical consequence, higher dose levels were used, specifi-
cally 6 and 7 mgr/kg. Later experiments were done on a paired 
basis: treated and untreated animals at the same time, using the 
same batch of endotoxin,in an effort to eliminate batch differen-
ces. 
Our results implicate that the generally accepted canine shock mo-
del, in which 5 mgr/kg endotoxin is considered to be a L.D. 95%, 
should be looked at with considerable scepsis. 
It appeared that even higher doses of endotoxin (6 and 7 mgr/kg 
bodyweight) did not result in death of all the untreated animals. 
Conclusions: 
5 Mgr/kg Endotoxin coli 0127:68 from different batches appeared 
not to be a L.D. 95%, but a L.D. 60% in our experimental set up. 
116 
C. 3-9 Extended registrations 
Objective: To investigate the trends of blood pressure, -flow and 
peripheral resistance later on in the second phase. 
Introduction: The experimental set up in which haemodynamic para-
meters were registrated up till 2l hrs. after the 
injection of endotoxin was based on considerations as described 
in chapter C. 3-2. 
Two hours after endotoxin administration the shock pattern was 
usually in a steady state. 
Swan (103) proved that haemodynamic parameters in late shock only 
changed in the last 15 min. before death of the experimental ani-
mal. The small number of experiments described in this chapter 
were performed to check whether in our experimental model any 
changes in the trend of blood pressure and -flow occurred later 
on in the second phase of shock. 
Materials and methods: Two paired experiments were done with 
6 mgr/kg and 7 mgr/kg endotoxin resp. 
The treated animals received biphasic blockade with 15 mgr/kg 
dibenzyline and 1,5 mgr/kg trasicor. 
Registration of shock parameters was continued for 51 hrs. after 
endotoxin. 
Results: 
Fig. 35,36,37,38,39,40,41 and 42 give the data (p. 120 up till 123). 
1. Experiments with 6 mgr/kg endotoxin: the S.B.P. in the treated 
animal (Fig. 35, p. 120) shows an upward course later on in 
the second phase. The same parameter in the untreated animal 
shows a steady decline in the second phase of shock Fig. 36, 
p. 120). A comparison of the blood flow in these experiments 
(Fig. 37, p. 121) shows a steady course in the later part of 
the second phase in the experiment with adrenergic blockade: 
the blood flow 5 hrs. after endotoxin (43 ml/min.) is roughly 
2/3 of the flow at the start of the experiment (69 ml/min). 
The untreated animal has a low flow state in the second phase 
with some further decline: the blood flow values 5 hr~ after 
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endotoxin (4,4 ml/min ) is here approximately 1/20 of the 
flow at start (85 ml/min). 
The peripheral resistances (Fig. 38, p. 121) showed a steady 
state at 5 hrs. after endotoxin. 
2. Experiments with 7 mgr/kg endotoxin: The S.B.P. in the treated 
and untreated experiments alike does not change essentially i~ 
~he later phase of shock (Fig. 39,p.122 and Fig. 40,p. 122). 
Jhe same applies for the flow in these experiments (Fig. 41, ~- 123):the flow 5 hrs. after endotoxin in the experiment with 
biphasic blockade (39 ml/min) is between 1/3 and 1/2 of the 
flow at the start of the experiment (90 ml/min). 
In the untreated animals the value 5 hrs. after endotoxin 
(5 ml/min) is approximately 1/14 of the flow at start (71 ml/ 
min). 
The peripheral resistances(Fig. 42,p. 123) do not change any-
more in the later phase of endotoxin shock. 
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Discussion and conclusions: 
Trends of blood pressure, -flow and peripheral resistance values 
did not change significantly later on in the second phase of 
shock up till 5! hrs. after endotoxin injection. 
Blood flow in the treated cases remained higher than in the un-
treated cases. 
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D. DISCUSSION AND CONCLUSIONS 
In chapter A. the outline of this study is given:the complexity of 
the syndrome of clinical gram-negative shock and the confusing 
and contradictory information found in literature on cause and 
mechanisms of this type of circulatory failure, led to further in-
vestigation of the subject. 
Evidence indicates that the bacterial endotoxins lead to shock 
via release of vasoactive mediators (chapter A.2). 
The catecholamines may play the primary role as vasoactive media-
tors, although histamine, serotonine, kinin and bradykinin also 
may have some vasoactive function in endotoxin shock(chapter B.3). 
Adrenergic effects are distinguished in alpha-receptor functions 
and beta-receptor functions , which can both be blocked pharma-
cologically (chapter B. 4). 
As discussed in chapter A. 2, this study on combined adrenergic 
blockade in canine endotoxin shock was started when no information 
on such a complete blockade could be found in literature. 
The dog was chosen as experimental animal, although it was reali-
zed that the canine model differs in certain haemodynamic aspects 
from the subhuman primate model and therefore most likely also 
from man (chapter A. 3). 
The endotoxin shock model was preferred over the viable bacteria 
shock model, because it are the endotoxins from the bacterial 
cell wall which cause shock, and it seemed that the endotoxin 
model would have more precise haemodynamic parameters (chapter 
A. 4). 
5 Mgr/kg bodyweight Endotoxin coli (0127:B8, Oifco) was chosen for 
our experiments, because several authors consider this dose to 
represent a L.D. 95% (subchapter B. 1-1-1). 
Endotoxin shock in dogs follows a biphasic pattern with hepato-
splanchnic pooling of blood in the first phase of shock and pro-
bably diffuse vasodilatation in the second phase (subchapter 
B. 1-2). More evidence is given in chapter B. 4, which seems to 
endorse the idea of blocking both adrenergic effects : Swan (104, 
105) proved that norepinenephrine and epinephrine have both alpha-
and beta-receptor functions. 
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If a conclusion can be made on the data given in literature, it 
would be that most likely alpha-blockade influences the first 
phase of canine endotoxin shock, and beta-blockade the second 
phase. 
Such a hypothesis and consequently a biphasic alpha-beta-adrener-
gic blockade has not been described in literature. 
Therefore, such a working hypothesis formed the basis of our in-
vestigation (chapter C. 1). 
An intriguing aspect of any treatment that would improve endo-
toxin shock is the fact that such a treatment might also be bene-
ficial in the endstages of haemorrhagic and cardiogenic shock. 
This can be concluded from the so called 'final common pathway 
theory**, described in subchapter B. 2-1, in which is stated that 
shock of any kind becomes ultimately endotoxic in nature, because 
the intestine after prolonged ischaemia loses its barrier func-
tion against passage of bacteria and endotoxins into the blood-
stream. 
Evidence as outlined by Fine (28, 29) and Lillehei (65, 67) seems 
conclusive on this point. 
In chapter C. 2, the results of the pilot study are described, in 
which the influence on canine endotoxin shock of alpha-blockade 
with dibenzyline and beta-blockade with inderal or trasicor was 
investigated. 
Biphasic blockade with dibenzyline and trasicor in high doses led 
to a significant improvement of survival (subchapter C. 2-3). 
It was demonstrated that even 15 mgr/kg dibenzyline was not the 
maximum dose with regard to its vasodilatory effects (subchapter 
c. 2-4). 
Another argument in favour of these high dosages was found in the 
observation that endotoxin circulated for a prolonged period of 
time after injection (subchapter C. 2-5). 
The increased levels of plasma catecholamines, found after endo-
toxin injection, seemed to support the validity of the catechol-
amine hypothesis in our model (subchapter C. 2-6). 
In the main study, the results of further analysis of this bipha-
sic blockade is described (chapter C. 3). 
The alpha-blockade with dibenzyline was given as premedication 
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before the injection of endotoxin, and directed to the first pha-
se of shock, immediately after endotoxin injection. 
The beta-blockade with trasicor was given as medication after en-
dotoxin injection and directed to the second phase of shock (sub-
chapter C. 3-2). 
Alternative methods of adrenergic blockade were also more exten-
sively investigated. At first, firm conclusions were impossible, 
because the supposedly lethal dose 95% (L.D. 95%) of 5 mgr/kg 
endotoxin appeared to have a lower lethality in control experi-
ments with endotoxin shock without treatment (subchapter C. 3-4). 
Whereas in the pilot study, no animals, treated or untreated, sur-
vived the procedure, in the main study not only treated, but also 
some untreated animals survived. 
This difference could have been due to the different dog model, 
used. in the main study, to differences of potency of the several 
endotoxin batches used, or to a decline of potency during storage 
time of the endotoxin. This problem is discussed in subchapter 
c. 3-8. 
The solution was then sought and found in extending the amount of 
experiments and comparing a larger group of treated animals with 
untreated counterparts. 
Experiments with higher doses of endotoxin (6 and 7 mgr/kg) were 
performed as well in an effort to reach a L.D. 95% shock ~odel 
(subchapter C. 3-7-2). 
When even 7 mgr/kg endotoxin appeared not to be a L.D. 95%, ex-
periments were paired for comparison of treated and untreated ani-
mals, injected with the same batch of endotoxin (subchapter C. 3-7). 
On the completed experimental data, statistical analysis was pos-
sible. The biphasic pattern of endotoxin shock in dogs was con-
firmed (subchapter C. 3-4). 
The conclusion was reached that biphasic blockade improved survi-
val significantly and resulted in a significantly higher blood 
flow after endotoxin injection (subchapter C. 3-7). 
Contrary to some information in literature (subchapter B. 4-3), 
dibenzyline was found to give a significant improvement of shock 
parameters in the first phase of canine endotoxin shock, which 
seems to endorse the hypothesis that this phase is largely an 
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alpha-adrenergic phenomenon. 
When solely dibenzyline premedication was given without trasicor 
in the second phase, the blood flow also remained high in the se-
cond phase after endotoxin, but at the expense of a significantly 
increased heart rate (subchapter C. 3-5-1). 
It can be concluded that the beneficial effect of beta-blockade 
in the second phase is mainly that the higher blood flow can be 
maintained with a normal heart rate (subchapter C. 3-7-1). 
In this respect also,the working hypothesis seemed to be suppor-
ted by the results of our investigation. 
Bet~-blockade after endotoxin injection withoutpremedicativeal-
phaJblockade (subchapter C. 3-5-2) and combined simultaneous 
I blockade as premedication (subchapter C. 3-6) were of no benefit. 
Adrenergic blockade prevented the sharp rise in peripheral resis-
1 
tan9e, that is characteristic for endotoxin shock (subchapters 
C. 3-4, C. 3-5-1 and C. 3-7). 
Thi~ prevention of general vasoconstriction is apparently one of 
the 'most important effects of adrenergic blockade in endotoxin 
shock. 
Evidently, in a clinical condition one cannot give a premedica-
tion with dibenzyline as in the experimental model. 
The eventual ''translation'' to a clinical situation should then 
probably be found in a very early start of such a therapy, when 
the first symptoms of septic shock are suspected. 
Nonetheless, application of this method in human septic shock 
seems premature and should be preceded by investigation of bipha-
sic adrenergic blockade in subhuman primates. 
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E. SUMMARY 
In the introduction the motives to undertake this investigation 
are outlined: although septic shock in man still has a high mor-
tality, basic research in this field did not give a satisfactory 
explanation of the syndrome. 
In the experimental model ,it was found that septic or gram-nega-
tive bacterial shock is caused by the bacterial endotoxins. The 
endotoxins lead to shock via vasoactive mediators. 
Among these possible mediators, the catecholamines may be the 
most important ones. In this case, adrenergic blockade could be 
of benefit in experimental endotoxin shock and probably also in 
man. 
Documentation of a combined adrenergic-receptor blockade in ex-
perimental endotoxin shock could not be found in literature. 
Therefore, such a combined blockade was investigated in the ani-
mal experiment. 
As the experimental model, endotoxin shock in dogs was chosen. 
In a literature survey this model and the possible role of the 
catecholamines in endotoxin shock was studied. 
Reports of various authors on separate adrenergic blockades in 
canine endotoxin shock are given. 
The own investigation started with a pilot study, in which the 
influence of several dosages and combinations of adrenergics on 
survival in canine endotoxin shock was studied. 
The effect of increasing dosages of dibenzyline (alpha-blockade) 
and additional trasicor (beta blockade) on vasodilatation, endo-
toxin circulation and plasma catecholamine levels were investigated. 
Biphasic blockade with 15 mgr/kg bodyweight dibenzyline and 
1,5 mgr/kg bodyweight trasicor in canine endotoxin shock was the 
main topic of interest. 
Alternative methods of adrenergic blockade were also investigated 
in this model. 
Results led to the conclusion that the biphasic blockade impro-
ved survival significantly, as compared with control experiments 
with endotoxin shock without treatment. 
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The blood flow was significantly higher in the treated group as 
compared to untreated animals. 
The higher blood flow was reached with a much lower heart rate, when 
beta-blockade was applied in the second phase of shock. 
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SAMENVATTING 
In de inleiding wordt vermeld waarom dit onderzoek werd verricht: 
hoewel de mortaliteit van septische shock bij mensen nog steeds 
hoog is, heeft het elementaire onderzoek op dit gebied nag geen 
afdoende verklaring voor het syndroom opgeleverd. 
In het experimentele proefmodel is aangetoond, dat septische of 
gram-negatieve bacteriele shock veroorzaakt wordt door bacteriele 
endotoxinen~ De endotoxinen veroorzaken shock door middel van 
stoffen die een invloed op de vaattonus hebben. 
Van deze mogelijke tussenstoffen zouden de catecholaminen demeest 
belangrijke kunnen zijn. Wanneer dit het geval is, zou een adre-
nergische blokkade van nut kunnen zijn in experimentele endotoxi-
sche shock en mogelijk ook bij de mens. 
In de literatuur kon geen beschrijving worden gevonden van een 
gecombineerde adrenergische receptor blokkade in experimentele 
endotoxische shock. 
Om deze reden werd een dergelijke gecombineerde blokkade onder-
zocht in het diermodel. 
Endotoxische shock bij honden werd gekozen als experimenteel model. 
In een literatuuroverzicht werd dit model en de mogelijke rol van 
de catecholaminen in endotoxische shock bestudeerd. 
Mededelingen van verschillende auteurs over aparte adrenergische 
blokkades in endotoxische shock bij de hond worden vermeld. 
Het eigen onderzoek begon met enkele voorlopige experimenten 
waarin de invloed van verscheidene doseringen en combinaties van 
anti-adrenergica op overleving in endotoxische shock bij de hand 
werden bestudeerd. 
Het effect van toenemende doseringen dibenzyline (alpha-blokkade) 
en toegevoegde trasicor (beta-blokkade) op vaatverwijding, endo-
toxine-circulatie en plasma catecholamine-gehalten, werd onder-
zocht. 
Biphasische blokkade met 15 mgr/kg lichaamsgewicht dibenzyline en 
1,5 mgr/kg lichaamsgewicht trasicor in endotoxische shock bij de 
hond was het belangrijkste doel van het onderzoek. 
Alternatieve methoden van adrenergische blokkade werden ook onder-
zocht in dit model. 
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De resultaten leidden tot de conclusie dat de biphasische blokka-
de de overleving,in vergelijking met controle experimenten met en-
dotoxische shock zonder behandeling, significant verbeterde. 
De bloedstroom was ook significant hager in de behandelde groep 
in vergeiijking met niet behandelde dieren. 
Met beta-blokkade in de t<~eede fase van shock werd deze hoge bloed-
stroom bereikt met een veel lagere hartfrequentie. 
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